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Background-—Mutations in aB-crystallin result in proteotoxic cardiomyopathy with desmin mislocalization to protein aggregates.
Intermittent fasting (IF) is a novel approach to activate transcription factor EB (TFEB), a master regulator of the autophagy-
lysosomal pathway, in the myocardium. We tested whether TFEB activation can be harnessed to treat advanced proteotoxic
cardiomyopathy.
Methods and Results-—Mice overexpressing the R120G mutant of aB-crystallin in cardiomyocytes (Myh6-CryABR120G) were
subjected to IF or ad-lib feeding, or transduced with adeno-associated virus–TFEB or adeno-associated virus—green ﬂuorescent
protein after development of advanced proteotoxic cardiomyopathy. Adeno-associated virus–short hairpin RNA–mediated
knockdown of TFEB and HSPB8 was performed simultaneously with IF. Myh6-CryABR120G mice demonstrated impaired
autophagic ﬂux, reduced lysosome abundance, and mammalian target of rapamycin activation in the myocardium. IF resulted in
mammalian target of rapamycin inhibition and nuclear translocation of TFEB with restored lysosome abundance and autophagic
ﬂux; and reduced aggregates with normalized desmin localization. IF also attenuated left ventricular dilation and myocardial
hypertrophy, increased percentage fractional shortening, and increased survival. Adeno-associated virus–TFEB transduction was
sufﬁcient to rescue cardiomyopathic manifestations, and resulted in reduced aggregates and normalized desmin localization in
Myh6-CryABR120G mice. CryABR120G-expressing hearts demonstrated increased interaction of desmin with aB-crystallin and
reduced interaction with chaperone protein, HSPB8, compared with wild type, which was reversed by both IF and TFEB
transduction. TFEB stimulated autophagic ﬂux to remove protein aggregates and transcriptionally upregulated HSPB8, to restore
normal desmin localization in CryABR120G-expressing cardiomyocytes. Short hairpin RNA–mediated knockdown of TFEB and
HSPB8 abrogated IF effects, in vivo.
Conclusions-—IF and TFEB activation are clinically relevant therapeutic strategies to rescue advanced R120G aB-crystallin mutant-
induced cardiomyopathy by normalizing desmin localization via autophagy-dependent and autophagy-independent mechanisms.
( J Am Heart Assoc. 2019;8:e010866. DOI: 10.1161/JAHA.118.010866.)
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M utations in sarcomeric and cardiac cytoskeletal pro-teins are being increasingly ascribed causative roles in
engendering cardiomyopathy spanning the spectrum of
dilated, hypertrophic, restrictive, and arrythmogenic right
ventricular dysplasia phenotypes.1 One such genetically
heterogeneous group of disorders, termed “desminopathies,”
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is characterized by a deﬁciency or mislocalization of desmin, a
muscle-speciﬁc type III intermediate ﬁlament that serves a
critical scaffolding role in linking the sarcomere to other
intracellular structures.2 A cardiac-enriched small heat shock
family protein, aB-crystallin, binds desmin; and a missense
mutation that leads to an arginine-to-glycine change at
position 120 (R120G) results in loss of its chaperone
function,3 with formation of protein aggregates that manifest
as an autosomal dominant cardiomyopathy, cataracts, and
skeletal myopathy in humans.4 Analogously, mutations in
desmin also provoke cardiomyopathy, and formation of
amyloid protein aggregates in cardiac myocytes is a hallmark
of disease pathogenesis.5 Whether facilitating removal of
protein aggregates can reverse established cardiomyopathy in
patients presenting with a full-blown disease process has not
been experimentally evaluated.
Protein aggregation leading to myoﬁbrillar degeneration
and sarcomere dysfunction,6–8 as well as cardiac myocyte
apoptosis and interstitial ﬁbrosis,9,10 have been implicated as
proximate mechanisms for development of the progressive
cardiomyopathy in mice with cardiomyocyte-speciﬁc expres-
sion of the R120G aB-crystallin mutant (CryABR120G)
protein. Although cardiomyocyte protein quality-control
pathways (namely, the heat shock family of chaperones,8
the ubiquitin-proteasome pathway,11 and autophagy)7 are
induced in these models, further upregulation of small heat
shock proteins,12,13 overexpression of an 11S subunit to
activate proteasomes,14 and stimulation of autophagy with
ATG7 overexpression or exercise15,16 are individually sufﬁ-
cient to prevent development of aggregates and attenuate
cardiomyopathy. Whether targeting these pathways individu-
ally or combinatorially rescues advanced cardiomyopathy with
CryABR120G expression has not been evaluated.
Mislocalization of desmin from its physiologic location in
association with Z-discs between sarcomeres and intercalated
discs at intercellular junctions to protein aggregates is a
common feature of CryABR120G-induced cardiomyopathy and
desmin-related cardiomyopathies in the human myocardium
and in animal models.6,17 CryABR120G-expressing mice as
well as mice with desmin mutations resulting in loss of its
sarcomeric localization demonstrate impaired cardiac myo-
cyte contractility9,17 and mitochondrial abnormalities9,18; and
desmin null mice demonstrate myoﬁbrillar breakdown with
accelerated cardiomyocyte death and cardiomyopathy,19,20
pointing to a critical role for desmin in cardiomyocyte
homeostasis. The CryABR120G mutant protein binds desmin
with increased afﬁnity compared with wild-type aB-crystallin
protein,21 is defective in chaperone function,3 and gets
ubiquitinated to be sequestered in aggregates6,7 or targeted
for proteolytic degradation. Formation of protein aggregates is
protective because strategies to reduce ubiquitination of
CryABR120G by targeting the COP9 (Constitutive photomor-
phogenesis 9) signalosome22 or preventing its aggregation by
depletion of p62,23 an adaptor protein that sequesters
ubiquitinated proteins in aggregates, enhance CryABR120G-
induced cytotoxicity. However, despite accelerating protein
aggregate pathologic features with age,10 cardiac function
progressively declines in CryABR120G-expressing hearts,7
suggesting the hypothesis that sequestration of other
proteins, such as desmin, within aggregates may play a
pathologic role in the progressive cardiomyopathy. Whether
strategies to correct desmin localization will be synergistic
with those targeting removal of protein aggregates remains to
be explored.
Cardiomyocyte autophagy plays a critical role in slowing
progression of CryABR120G-induced cardiomyopathy because
concomitant haploinsufﬁciency of Beclin-1 resulted in accel-
erated disease progression in a mouse model of human
CryABR120G protein expression.7 In studies presented
herein, we have uncovered impairment in autophagic ﬂux at
an advanced, preterminal stage of cardiomyopathy, associ-
ated with inactivation of transcription factor EB (TFEB), the
master regulator of autophagy and lysosomal machinery.24
Concurrently, we found hyperactivation of mammalian target
of rapamycin (mTOR), the kinase that phosphorylates and
Clinical Perspective
What Is New?
• Advanced cardiomyopathy, induced by expression of the
R120G mutant of the small heat shock protein, aB-
crystallin, can be rescued by intermittent fasting and
adeno-associated virus–mediated gene therapy to trans-
duce transcription factor EB, a master regulator of
autophagy-lysosome pathway.
• Transcription factor EB activation by intermittent fasting and
adeno-associated virus–mediated gene delivery accelerates
protein aggregate removal, and permits physiologic relocal-
ization of desmin away from the aggregates to the Z-discs
and intercalated discs by transcriptional induction of
HSPB8, another member of the small heat shock protein
family.
What Are the Clinical Implications?
• Intermittent fasting and adeno-associated virus–mediated
transcription factor EB gene delivery are promising trans-
lational strategies to abrogate cardiomyopathic manifesta-
tions with protein-aggregate pathologic features in the
myocardium.
• These paradigms may also be broadly applicable
to prevention and/or treatment of cardiomyopathies
characterized by desmin mislocalization and related
“desminopathies.”
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inactivates TFEB, thus keeping it sequestered and inactive in
the cytosol.25 We have observed that fasting is a potent
stimulus for TFEB activation in the myocardium and that
intermittent fasting (IF) facilitates mitochondrial quality
control and preconditions the myocardium to ischemia-
reperfusion injury.26 Herein, we have evaluated the feasibility
of IF and TFEB gene therapy, as a strategy to rescue advanced
cardiomyopathy resulting from expression of the R120G
aB-crystallin mutant protein. Our ﬁndings reveal that TFEB
activation coordinately drives protein quality control
pathways in the myocardium to restore normal desmin
localization via accelerating autophagic removal of protein
aggregates and transcriptional induction of HSPB8 (Heat
Shock Protein Family B (Small) Member 8), to attenuate
established cardiomyopathy.
Methods
The authors declare that all supporting data are available
within the article. The data, analytic methods, and study
materials will be made available to other researchers for
purposes of reproducing the results or replicating the
procedures reported in this article.
Studies in Mice
Transgenic mice with cardiomyocyte-speciﬁc expression of
R120G mutant of human aB-crystallin protein (ie, Myh6-
CryABR120G transgenic mice described previously)8 and age-
and sex-matched littermate controls were used for all the
studies. CryAB null mice27 were generously provided by Dr
Eric Wawrousek. Echocardiographic studies and IF were
performed as previously described (also see Data S1 for
details).26 Terminal studies on mice were initiated between 8
and 10 AM after an overnight period of feeding (ie, on a fed
day). All animal studies were approved by the Institutional
Animal Care and Use Committees at Washington University
School of Medicine and at the John Cochran VA Medical
Center. Assessment of autophagic ﬂux, in vivo, was performed
with injection of chloroquine (40 mg/kg IP, Sigma catalog No.
C6628) 4 hours before euthanasia, as previously described.26
Ultrastructural Examination
Transmission electron microscopy was performed on mice
hearts ﬁxed in a modiﬁed Karnovsky’s ﬁxative, followed by
imaging with a JEOL model 1200 EX electron microscope
(JEOL, Tokyo, Japan), as previously described.26
Quantitative Polymerase Chain Reaction Analysis
Total RNA was extracted from mouse hearts or neonatal rat
cardiac myocytes (NRCMs) using RNAeasy Fibrous Tissue Kit
(Qiagen, 74704) or the Mini kit (Qiagen, 74104), respectively.
Quantitative polymerase chain reaction analysis was per-
formed as described.26 Primers used are shown in Table S1.
Assessment of Mitochondrial DNA Content
DNA was extracted from NRCMs modeled with adenoviral
gain-of function and loss-of-function approach pellets, and
real-time quantitative polymerase chain reaction was per-
formed for the mitochondrial gene NADH2 (with primers
50-ATCACCACCATTCTCGCAAT-30 and 50-TCCTATGTGGGCAA
TTGATG-30) and the nuclear gene RCAN1 (with primers 50-GG
TTTGCTGAGCCTCGAAG-30 and 50-CTTCATCCCTCCTTTGTAAC-
30). The ratio of copies of mitochondrial/nuclear genes was
calculated to represent the relative mitochondrial DNA
content, as we have previously described.28
Generation of Adenoviral Constructs
Adenoviral particles coding for LacZ and human TFEB with
N-terminal FLAG have been described previously.29 Adenoviral
particles for expression of short hairpin RNA (shRNA)
targeting rat hspb8 and a LacZ shRNA control were generated
with BLOCKiT adenoviral system (Invitrogen, K4941–00).
Speciﬁc oligonucleotide sequences used were as follows:
shRNA targeting rat hspb8–top strand oligonucleotide, 50- CA
CCGTCAAAGTATTGGGAGGTTCGAAAACCTCCCAATACTTTGAC-
30; bottom strand oligonucleotide, 50-AAAAGTCAAAGTATTGGG
AGGTTTTCGAACCTCCCAATACTTTGAC-30. Adenoviruses were
generated in HEK293A cells and titered per the manufac-
turer’s instructions.
Generation of Adeno-Associated Virus Constructs
Mouse TFEB cDNA was cloned into a phosphorylated adeno-
associated virus (AAV9) vector containing the CMV (cytome-
galovirus) promoter (phosphorylated AAV9–CMV–FLAG–
TFEB), as we have previously described.30 Coding sequences
for human CRYAB and CRYAB protein with the R120G
mutation were similarly cloned into a phosphorylated AAV9
vector containing the cardiac-speciﬁc troponin T promoter.31
Constructs for in vivo knockdown of mouse endogenous TFEB
and HSPB8 were generated using the speciﬁc oligonucleotide
sequences targeting murine TFEB (50-CGGCAGTACTATGAC
TATGAT-30) and HSPB8 (50-GCCTTGGAAAGTGTGTGTCAA-30);
and compared with a scrambled control sequence (with no
complementarity to murine genome) (50-CCTAAGGTTAAGTC
GCCCTCG-30) by cloning into an AAV9 vector under the
control of a U6 promoter. AAV9 particles were generated at
the Hope Center Viral Vectors Core at Washington University
School of Medicine. A 1-time dose of 3.591011 particles was
administered to the mice by tail vein injection.
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Subcellular Fractionation Into Cytoplasmic and
Nuclear Fractions
Hearts were fractionated into nucleus-enriched and cytoplas-
mic samples by using a CelLytic NuCLEAR extraction kit
(Sigma), as previously described.26
Isolation of Soluble and Insoluble Fractions
Heart tissue was fractionated into soluble and insoluble
fractions, as previously described (also see Data S1 for details).7
Immunoblotting
Crude cardiac or NRCM extracts were prepared, followed by
immunoblotting, as described.26 Antibodies used were as
follows: LAMP2 (Lysosomal Associated Membrane Protein 2),
mouse monoclonal (Developmental Studies Hybridoma Bank,
ABL-93); LAMP1 (Santa Cruz Biotechnology, sc-19992); anti-
LC3 (encoding for MAP1LC3B (Microtubule Associated Protein
1 Light Chain 3 Beta) subunit; Novus Biologicals, NB100–2220);
SQSTM1 (Sequestosome 1) (Abcam, ab5416); TFEB (Bethyl
Labs, A303–673A); HA (H6908; Sigma), p70S6K (phosphory-
lated Ribosomal protein S6 kinase beta-1) (2708; Cell Signal-
ing); phosphorylated p70S6K (9234; Cell Signaling); 4-EBP1
(Eukaryotic translation initiation factor 4E-binding protein 1)
(9644; Cell Signaling); phosphorylated 4EBP1 (2855; Cell
Signaling); phosphorylated mTOR (2974; Cell Signaling); mTOR
(2983; Cell Signaling); histone H3 (9715, Cell Signaling);
GAPDH (ab22555; Abcam); Hspb8 (3059S, Cell signaling); and
ACTA1/a-sarcomeric actin (Abcam, ab7799) or actin (Sigma,
A2066). Protein abundance was normalized to actin or GAPDH
protein expression and reported as fold change versus control.
Immunoﬂuorescence Analysis
Primary cultures of NRCMs26 were ﬁxed in 100% cold methanol
for 20 minutes, followed by blocking with 1% normal serum in
PBS for 1 hour at room temperature. Primary antibodies used
were as follows: anti-desmin (Santa Cruz Biotechnology, Inc,
SC-7559), anti–aB-crystallin polyclonal antibody (ENZO Life,
ADI-SPA-223-F), anti-p62/SQSTM1 (PROGEN Biotechnik,
GP62-C), anti–ubiquitinated FK-2 (Millipore; 04-263), and TFEB
(Bethyl Labs, A303–673A) with overnight incubation at 4°C.
Parafﬁn-embedded heart sections (10 µm thick) were sub-
jected to heat-induced epitope retrieval, followed by blocking,
and incubated overnight with primary antibody against desmin
(Santa Cruz Biotechnology, SC-7559). After serial washes,
samples were stained with AlexaFluor488 (Invitrogen) and
mounted with ﬂuorescent 4’,6-diamidino-2-phenylindole
mounting medium (Vector Labs, H-1200). Confocal imaging
was performed on a Zeiss confocal LSM-700 laser scanning
confocal microscope using 639 Zeiss Plan-Neoﬂuar 409/1.3
and 639/1.4 oil immersion objectives, and images were
acquired using Zen 2010 software. Assessment of terminal
deoxynucleotidyl transferase-mediated dUTP nick-end labeling
positivity in myocardial samples was performed as previously
described.26 Intracellular protein aggregates in cardiac myo-
cytes were quantitated on 920 images of parafﬁn-ﬁxed tissue
immunostained for desmin. Aggregates were identiﬁed using
the ImageJ software by counting particles greater than a
predeﬁned threshold size and assessing an automated aggre-
gate area as a percentage of the total area. A minimum of 10
images per heart were counted to obtain the average aggregate
area percentage. At least 3 biological replicates were assessed
for each group.
Flow Cytometry
NRCMs were incubated with JC-1 (10 mg/mL for 10 minutes)
at 37°C in 5% CO2, followed by trypsinization and ﬂow
cytometry on a FACScan instrument (Becton-Dickinson), as
previously described.26 Cyﬂogic software was used to analyze
20 000 events per run.
Assessment of Cell Death
Cell death assays were performed in 96-well plates with a
Live-Dead cytotoxicity viability kit for mammalian cells
(Invitrogen), as described previously.26
Coimmunoprecipitation Assays
One milligram of protein from the mouse hearts was
incubated with anti-desmin (SC7559; Santa Cruz Biotechnol-
ogy), anti-mouse FLAG (F3165; Sigma), and normal goat IgG
(SC2028, Santa Cruz Biotechnology) or normal mouse IgG
(SC2025, Santa Cruz Biotechnology); immunoprecipitation
was performed using Dynabeads Protein G Immunoprecipita-
tion Kit (Thermo Fisher Scientiﬁc, 10007D). The eluted
samples are analyzed by SDS-PAGE, followed by Western
blot, to detect desmin (anti-desmin, D1033, Sigma), aB-
crystallin (anti–aB-crystallin, ADI-SPA-223-F, Enzo Life), and
HSPB8/HSP22 (anti-HSPB8/HSP22, 3059S, Cell Signaling).
Statistical Analysis
Results are expressed as meanSEM. Statistical differences
were assessed with the unpaired Student t test for 2
independent groups and ANOVA for comparing results across
multiple groups with GraphPad Prism software. Tukey’s post
hoc test was used after ANOVA for testing all pair-wise
comparisons. To overcome the limitations with large-sample
approximations using the above approaches, we redid the
analysis using 2 additional statistical software programs for
comparing results: R and SAS. With R, we performed t tests
with permutation correction for P values by using permTS
function of library “perm” of R, selecting method=“exact.ce” in
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permTS for a complete enumeration. We also tested such
analyses via MULTTEST of SAS with mean t test for continuous
variables by selecting “pooled” degrees of freedommethod, “2-
tailed” tails for continuous tests, and “permutation” P-value
adjustment by selecting “20 000” number of resamples and a
random seed. Application of the permTS (R) and MULTTEST
(SAS) produced identical results. We have reported the R
permTS function P value in Data S1 for quantitative analyses
presented in Figures 1 through 8. Log-rank statistic was used
to assess differences in survival. A 2-tailed value of P<0.05 was
considered statistically signiﬁcant.
Results
Autophagic Flux Is Impaired in CryABR120G
Transgenic Mice With Advanced Cardiomyopathy
To address the role of autophagy in treatment of established
CryABR120G-induced cardiomyopathy, as typically observed
in individuals harboring this mutation when they ﬁrst seek
clinical attention,2 we examined autophagic ﬂux in 40-week-
old transgenic mice expressing the human R120G aB-crystallin
mutant protein in cardiac myocytes (Myh6-CryABR120G). A
sudden and marked increase in mortality is observed at this
time in this model,8 accompanying widespread protein aggre-
gate pathologic features in cardiomyocytes and an end-stage
cardiomyopathy phenotype. As shown in Figure 1A through
1C, short-term inhibition of lysosomal acidiﬁcation with
chloroquine resulted in accumulation of LC3-II (the autophago-
some bound form of LC3, an index of autophagosome
abundance) and p62 (SQSTM1, an adaptor protein that
becomes degraded via autophagy) in wild-type hearts com-
pared with diluent-treated counterparts. Myh6-CryABR120G
transgenic hearts demonstrated a marked increase in both
LC3-II and p62 compared with wild type, which did not change
further with chloroquine treatment (Figure 1A through 1C). To
conﬁrm that chloroquine treatment was effective in impairing
autophagosome processing in the Myh6-CryABR120G
Figure 1. Autophagic ﬂux is impaired in aB-crystallin R120G mutant transgenic mice with onset of heart failure. A through D, Representative
immunoblots (A) demonstrating expression of LC3 with quantitation of LC3-II (B), p62 (C) and aB-crystallin (D) in Myh6-CryABR120G transgenic
mice or littermate wild-type (WT) controls at 40 weeks of age, injected with chloroquine (40 mg/kg) or diluent to assess autophagic ﬂux. N=4 to
6/group. E, Representative myocardial transmission electron micrographs from in Myh6-CryABR120G transgenic mice or littermate WT controls
at 40 weeks of age. Arrows point to Z-discs, and arrowheads point to autophagic structures. Representative of N=2/group. *P<0.05.
DOI: 10.1161/JAHA.118.010866 Journal of the American Heart Association 5
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transgenic mice, we also evaluated autophagic ﬂux in
skeletal muscle tissue. Unlike the decreased ﬂux noted in
cardiac tissue, chloroquine induced accumulation of LC3-II
and p62 in skeletal muscle, indicating a cardiac-speciﬁc
suppression of autophagic ﬂux in this model (Figure S1A).
Furthermore, in younger mice without evidence of heart
failure, autophagic ﬂux was preserved (Figure S1B and S1C).
Taken together, these data indicate impaired ﬂux through
macroautophagy (henceforth termed “autophagy”) in Myh6-
CryABR120G transgenics with advanced cardiomyopathy
compared with the preserved ﬂux seen in wild-type controls.
Interestingly, aB-crystallin levels are also upregulated in
chloroquine- versus diluent-treated wild-type hearts (Fig-
ure 1A and 1D), indicating the normal turnover of this
chaperone is, at least in part, via autophagy in mice at this
age. Interestingly, cardiac extracts from Myh6-CryABR120G
transgenic mice demonstrated both slower and faster
migrating bands on PAGE gels, which were conﬁrmed to be
aB-crystallin protein (Figure S2) and likely represent ubiqui-
tinated aggregates and cleavage products of the mutant
crystallin protein, respectively, as previously described.22 The
abundance of aB-crystallin protein did not change with
chloroquine treatment in the Myh6-CryABR120G transgenic
mice, consistent with impaired autophagic ﬂux (Figure 1A
and 1D). Ultrastructural examination of the cardiomyopathic
Myh6-CryABR120G myocardium in aged mice revealed
accumulation of multiple autophagic structures (arrowheads,
Figure 1E) as well as effaced Z-discs (arrows, Figure 1E; with
broad and often zig-zag patterned Z-discs in transgenics, as
previously observed in a transgenic model with overexpres-
sion of mouse CryABR120G protein6 versus sharp Z-discs in
controls), consistent with the altered localization of desmin
adjacent to the Z-disc in this condition.
IF Restores Autophagic Flux and Rescues
Lethality in CryABR120G Transgenic Mice With
Advanced Cardiomyopathy
We have observed that IF transcriptionally upregulates the
autophagy-lysosome machinery and stimulates autophagic ﬂux
to precondition the heart to ischemia-reperfusion injury and
reduce cardiomyocyte cell death.26 More important, in this
study, IF did not affect cardiac structure or function in wild-type
mice.26 Accordingly, we tested if IF could rescue the impaired
autophagic ﬂux in the immediate preterminal stage in Myh6-
CryABR120G transgenic mice with advanced cardiomyopathy
(Figure 2A). Remarkably, IF over a period of 6 weeks com-
pletely prevented the mortality observed inMyh6-CryABR120G
mice over this period (Figure 2B). Examination of the state of
activation of TFEB, the master regulator of the autophagy-
lysosome machinery, revealed that in comparison to age-
matched wild-type controls, the abundance of nuclear TFEB
(where it localizes to upon activation)25 was similar and
cytosolic TFEB levelswere reduced (Figure 2Cand2D). Because
TFEB transcriptionally autoregulates its own expression,32
these data point to a failure of the transcriptional response
that drives the autophagy-lysosome pathway despite active
protein aggregate pathologic features, consistent with the
previous observation of reduced autophagy-lysosome pathway
gene transcripts in mice with transgenic expression of the
murine CryABR120G mutant.15,33,34 Interestingly, IF signiﬁ-
cantly increasednuclear TFEBabundance inMyh6-CryABR120G
mice comparedwith their ad-lib fedcounterparts (Figure 2Cand
2D), and this was associated with rescue of autophagic ﬂux
impairment, as indicated with chloroquine-induced upregula-
tion of LC3-II and p62 levels versus respective diluent-treated
group (Figure 2E and 2F). The lack of TFEB activation was
accompanied by reduction in LAMP1 and LAMP2 levels in ad-lib
fedMyh6-CryABR120G mice (versus wild-type mice, Figure 2G
and 2H), suggestive of a reduction in lysosome abundance,
which was restored to wild-type levels with IF. To examine
the mechanism for the lack of TFEB activation despite the
advanced protein-aggregate pathologic features in the Myh6-
CryABR120G myocardium, we assayed mTOR activity, which
phosphorylates TFEB to prevent its nuclear translocation.25
Aged Myh6-CryABR120G mouse hearts demonstrated
increased levels of phosphorylated mTOR and its substrates,
p70S6 kinase and 4EBP1, compared with wild-type hearts,
indicating increased mTOR activity, as observed previously in
mice with transgenic expression of the murine CryABR120G
mutant,34 which was attenuated with IF (Figure 2I and 2J).
IF Accelerates Protein Aggregate Removal in
CryABR120G Transgenic Hearts
Prior studies have demonstrated that activation of autophagy
is both necessary and sufﬁcient to prevent formation of
protein aggregates in cardiac myocytes expressing the
CryABR120G protein.7,33 To determine if restoration of
autophagic ﬂux was sufﬁcient to remove protein aggregates,
we examined aB-crystallin protein expression in Myh6-
CryABR120G transgenic hearts fractionated into soluble and
insoluble fractions.7 As shown in Figure 3A through 3C,
intermittently fasted mice demonstrated reduced levels of
soluble aB-crystallin protein, as well as insoluble aB-crystallin
either in monomeric or aggregate form, compared with ad-lib
fed counterparts. Examination of myocardial ultrastructure
demonstrated qualitatively fewer protein aggregates (Fig-
ure 3D, white arrows), with more abundant autolysosomes
(black arrows), and reappearance of sharp Z-discs, as seen in
wild-type controls, indicating partial restoration of Z-disc
ultrastructure in Myh6-CryABR120G transgenic hearts with
advanced cardiomyopathy (black arrowheads, compare with
broad Z-discs in ad-lib fed Myh6-CryABR120G myocardium).
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IF Attenuates Cardiomyopathy and Restores
Desmin Localization in CryABR120G
Transgenic Mice
Echocardiographic characterization of intermittently fasted
and ad-lib fed Myh6-CryABR120G mice revealed attenuation
of left ventricular (LV) dilation (Figure 4A and 4B, Table S2),
improved ejection performance (percentage LV endocardial
fractional shortening, Figure 4A and 4C, Table S2), and
attenuated hypertrophy (with reduced LV mass [Figure 4A and
4D] and heart weight [Figure 4A and 4E]) with IF, indicating
that restoration of autophagic ﬂux with IF correlated with
Figure 2. Intermittent fasting (IF) activates transcription factor EB (TFEB) and restores autophagic ﬂux in
aB-crystallin R120G mutant transgenic mice. A, Schematic depicting experimental intervention with IF in
Myh6-CryABR120G transgenic mice. B, Survival curves in IF and ad-lib (AL) fedMyh6-CryABR120G transgenic
mice and AL fed controls over the 6-week experimental duration. P value depicted is by log-rank test. C and D,
Representative immunoblots (C) demonstrating expression of TFEB with quantitation (D) in the cytosolic and
nuclear fractions from hearts ofmice treated as inA (at 46 weeks) and subjected to biochemical fractionation.
Expression of GAPDH and histone H3 is used to detect enrichment of cytosolic and nuclear proteins,
respectively. N=4/group. E, Assessment of autophagic ﬂux in mice Myh6-CryABR120G transgenic mice
subjected to IF or provided access to food AL as in A, and injected with chloroquine (40 mg/kg for 4 hours) or
diluent with immunoblotting for LC3 and p62. F, Quantitation of LC3-II and p62 in cardiac tissue from mice
treated as in E. N=4/group. G and H, Representative immunoblot (G) with quantitation (H) of lysosome
proteins LAMP1 and LAMP2 in total cardiac protein extracts from Myh6-CryABR120G transgenic mice
subjected to IF or AL feeding, or littermate wild type (WT) as in A. N=4/group. I and J, Representative
immunoblots (I) demonstrating expression of mammalian target of rapamycin (mTOR) pathway proteins with
quantitation (J) of phosphorylated mTOR (p-mTOR), phosphorylated 70S6K (p-S6K), and phosphorylated
4EBP1 (p-4EBP1) inMyh6–aB-crystallin R120G transgenic mice subjected to IF or AL feeding, andWT controls
as in A. N=4/group. qOD (every other day). *P value by post hoc test after 1-way ANOVA.
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attenuation of typical progression of the fatal cardiomyopathic
manifestations, otherwise observed with expression of
CryABR120G protein.6,8 Intermittently fastedMyh6-CryABR120G
myocardium demonstrated fewer eosinophilic aggregates
(Figure 4F [arrows] and 4H, with quantiﬁcation in Figure S3A)
with reduction in myocardial ﬁbrosis (Figure 4G) and cell
death (Figure S3B and S3C) compared with ad-lib counter-
parts. We also observed that the normal distribution of
desmin associated with Z-discs (multiple arrows in groups)
and intercalated discs (single arrow) seen in wild-type
cardiomyocytes was largely lost in Myh6-CryABR120G trans-
genic mice and replaced by desmin localized to aggregates
(Figure 4H, with appearance of a hollow core on immunohis-
tochemistry secondary to lack of antibody penetration into
aggregates, as observed previously6). Intriguingly, IF restored
the expression of desmin in association with Z-discs and
intercalated discs (Figure 4H; multiple arrows in groups and
single arrows, respectively) in the Myh6-CryABR120G myo-
cardium. To determine if this was secondary to synthesis of
new desmin, we measured its transcripts. Our data demonstrate
that although desmin transcripts are induced in Myh6-
CryABR120G hearts (versus wild type, Figure S4A), presumably
to compensate for reduced desmin localized to Z-discs and
intercalated discs, we did not see further upregulation with
IF, which suggests that IF restored localization of preexisting
desmin associated with removal of the aB-crystallin
aggregates.
AAV9-Mediated TFEB Transduction Rescues
Advanced Cardiomyopathy in CryABR120G
Transgenic Mice
We next tested if TFEB activation was sufﬁcient to attenuate
the cardiomyopathic manifestations in Myh6-CryABR120G
mice at an advanced stage of disease. To do so in a clinically
relevant manner, we performed AAV9-mediated gene transfer
of mouse TFEB via intravenous injection (versus AAV9–green
ﬂuorescent protein as control) at 36 weeks of age and
Figure 2. Continued
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conﬁrmed cardiac myocyte targeting at 40 weeks of age
(Figure 5A; data not shown and vide infra). AAV9-mediated
TFEB transduction resulted in modest upregulation of myocar-
dial TFEB abundance (2-fold over control, see Figure 5B and
5C [left]) with increased abundance of nuclear TFEB (Fig-
ure S5A) and of TFEB target proteins (Figure S5B through
S5F). This was sufﬁcient to result in reduced abundance of
aB-crystallin, including the higher-molecular-weight forms
versus AAV9–green ﬂuorescent protein transduced myocar-
dium (Figure 5B and 5C [right]) without affecting human
CryABR120G transgene transcript levels (Figure S6A), gener-
alized protein synthesis (Figure S6B and S6C), or mTOR
activity (Figure S6D). More important, a modest upregulation
of myocardial TFEB levels did not adversely affect left
ventricular structure or function or myocardial architecture
and ﬁbrosis compared with AAV9–green ﬂuorescent protein
transduced controls (Figure 5D through 5J). AAV9-mediated
TFEB transduction improved LV ejection performance (LV
percentage fractional shortening; Figure 5D and 5F, Table S3),
signiﬁcantly reduced LV end-systolic diameter (Table S3), and
attenuated hypertrophy (with reduced LV mass [Figure 5D
and 5G, Table S3] and heart weight [Figure 5D and 5H])
without an effect on LV dilation (Figure 5D and 5E, Table S3)
in Myh6-CryABR120G mice with advanced cardiomyopathy.
This was associated with reduced aggregates in the
myocardium (Figure 5I, Figure S7A), reduced ﬁbrosis (Fig-
ure 5J), and reduced myocardial cell death (Figure S7B and
S7C), consistent with the notion that exogenous TFEB was
sufﬁcient to remove protein aggregates and attenuate
cardiomyopathic manifestations at an advanced stage of
pathology in mice expressing CryABR120G, mimicking the
beneﬁts observed with IF (Figure 4).
TFEB Activation Alters Desmin Interaction With
aB-Crystallin and HSPB8 to Restore Desmin
Localization in CryABR120G Cardiomyopathic
Hearts
We next examined if TFEB transduction altered desmin
localization. AAV9-mediated TFEB transduction did not affect
desmin localization associated with the Z-discs (multiple
arrows in groups, Figure 6A) or the intercalated discs (single
arrow, Figure 6A) in wild-type mice. More important, AAV9-
TFEB transduction restored the normal pattern of desmin
Figure 3. Intermittent fasting (IF) promotes myocardial protein aggregate removal in aB-crystallin R120G mutant transgenic mice. A through C,
Representative immunoblot (A) with quantitation of aB-crystallin in the soluble (B) and insoluble (C) myocardial fractions fromMyh6-CryABR120G
transgenic mice subjected to IF or ad-lib (AL) feeding, and littermate wild-type (WT) controls at 46 weeks of age. N=4/group. P value is by t test.
“Darker” and “lighter” indicate relative exposures of the same blot. D, Representative TEM (Transmission electron microscopy) images from
Myh6-CryABR120G transgenic mice subjected to IF or AL feeding and littermate WT mice. White arrows point to protein aggregates. Black arrows
point to autolysosomes. Black arrowheads point to Z-discs, where intracellular desmin is localized, pointing to partial restoration of Z-disc
architecture in intermittently fasted Myh6-CryABR120G transgenic mice compared with AL fed controls. Representative of N=2/group.
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localization associated with the Z-discs and intercalated discs
in the Myh6-CryABR120G myocardium, in cardiomyocytes
that demonstrate nuclear TFEB expression (Figure 6A). This
suggested the hypothesis that TFEB transcriptionally upreg-
ulates other members of the heat shock protein family to
chaperone desmin to its normal localization. Prior studies
have suggested that expression of recombinant HSPB1
(HSP22) and HSPB8 (HSP25), 2 members of the non–
ATPase-dependent heat shock protein family that aB-crystal-
lin belongs to, are sufﬁcient to prevent CryABR120G amyloid
oligomer formation.12 In addition, induction of HSPB8 either
genetically or pharmacologically attenuated the development
of cardiomyopathic manifestations in mice expressing
CryABR120G in cardiac myocytes.35 We examined the protein
levels of these 2 small heat shock family proteins in the TFEB
(or green ﬂuorescent protein)–transduced Myh6-CryABR120G
transgenic mice and wild-type controls, and found that both
are increased in Myh6-CryABR120G transgenic myocardium
versus control (Figure 6B through 6D). Interestingly, TFEB
transduction resulted in further increase in protein levels of
HSPB8 (Figure 6B and 6C), but not HSPB1 (Figure 6B and
6D), in both wild-type and Myh6-CryABR120G transgenic
mice, consistent with the previously described presence of
TFEB-binding CLEAR (Coordinated Lysosomal Expression and
Regulation) sites in the HSPB8 promoter.36 Indeed, exoge-
nous TFEB was sufﬁcient to selectively upregulate HSPB8
transcripts in NRCMs after short-term transduction (Fig-
ure S8). Interestingly, myocardial HSPB8 transcript and
protein levels were also upregulated with fasting (Figure S9A
through S9C) and return to baseline levels with refeeding
(Figure S9B and S9C), tracking the pulsed activation of
myocardial TFEB with each episode that we have described
previously,26 without an increase on a fed day noted at the
termination of the 6 weeks of IF (Figure S9D and S9E).
The mechanism for TFEB-induced normalization of desmin
localization could be increased degradation of desmin from
the protein aggregates and resynthesis of new desmin that
gets chaperoned to its right location. We determined this to
be less likely because we did not detect a change in total
desmin protein abundance (Figure 6B and 6E) or in desmin
transcripts in the AAV9-TFEB treated samples (Figure S4B).
The alternative explanation is that desmin protein is held in
a strong interaction with the mutant aB-crystallin protein,21
which is targeted to the aggregates. Indeed, immunoprecip-
itation studies with AAV9-based cardiac-myocyte speciﬁc
expression of R120G mutant of CryAB and wild-type CryAB
Figure 4. Intermittent fasting (IF) attenuates cardiomyopathy in aB-crystallin R120G mutant transgenic
mice and restores normal desmin localization. A, Representative 2-dimensional–directed M-mode
echocardiographic images in Myh6-CryABR120G transgenic mice subjected to IF or ad-lib feeding for
6 weeks or ad-lib fed littermate wild-type (WT) mice at 46 weeks of age. B through E, Quantitation of left
ventricular end-diastolic diameter (LVEDD; B), left ventricular percentage endocardial fractional shortening
(LV %FS; C), left ventricular mass (LVM; D), and heart weight normalized to tibial length (HW/TL; E) in mice
treated as in A. N=5 to 7 mice/group. See Table S2 for additional echocardiographic data on these mice. F
through H, Representative images demonstrating myocardial sections stained with hematoxylin-eosin (H
and E; F) and Masson’s trichrome (G) and immunostained for desmin expression (H) in mice treated as in A.
White arrows in F point to eosinophilic protein aggregates. In H, white arrows in groups point to Z-discs and
arrowheads indicate I lines to demonstrate desmin localization. Single long white arrows point to desmin
localized in aggregates.
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proteins, driven by the cardiac troponin T promoter,31
demonstrate that desmin interacts more avidly with the
mutant protein, in vivo (Figure S10A through S10D). TFEB-
mediated autophagic removal of the ubiquitinated mutant
aB-crystallin protein then frees up desmin, which binds to
HSPB8 and is chaperoned back to its normal location in
association with the Z-discs and intercalated discs. Indeed,
coimmunoprecipitation experiments demonstrated that des-
min interaction with aB-crystallin is markedly upregulated in
the Myh6-CryABR120G hearts, whereas its interaction with
HSPB8 is concurrently diminished compared with wild type
(Figure 6F). Interestingly, both IF and AAV9-TFEB transduc-
tion resulted in a downregulation of desmin’s interaction
with aB-crystallin with a simultaneous increase in HSPB8
protein that was immunoprecipitated with desmin (Figure 6F
and 6G); and IF did not alter ubiquitination of desmin
(Figure S11). Taken together, these data suggest that TFEB
accelerates clearance of the mutant aB-crystallin protein
that sequesters desmin, whereby desmin is freed up to
interact with HSPB8 and is, therefore, able to return to its
correct location adjacent to the Z-discs and intercalated
discs.
TFEB Increases Autophagic Flux to Drive
Degradation of Mutant aB-Crystallin Independent
of HSPB8 Induction
To examine the effect of targeting TFEB activation and the role
of HSPB8 in autophagic removal of protein aggregates, we
adenovirally transduced CryABR120G in NRCMs together with
exogenous TFEB, with and without concomitant shRNA-
mediated HSPB8 knockdown (Figure S12A). TFEB transduction
upregulated HSPB8 protein abundance (Figure S12A and S12B)
and induced autophagic ﬂux in control-adenovirus transduced
myocytes, with accumulation of LC3-II and p62 in cells treated
with baﬁlomycin A1 to inhibit lysosomal acidiﬁcation versus
diluent-treated controls (Figure S12A, S12C, and S12D).
Expression of R120G aB-crystallin mutant resulted in impaired
autophagic ﬂux (lack of baﬁlomycin A1–induced accumulation of
LC3-II and p62 [Figure S12A, S12C, and S12D]), whereas
concomitant TFEB transduction restored autophagic ﬂux. More
important, knockdown of HSPB8 did not prevent TFEB-induced
upregulation of autophagicﬂux (FigureS12A, S12C, andS12D) in
cardiomyocytes expressing either CryABR120G or control. TFEB
transduction resulted in reduced expression of aB-crystallin
Figure 4. Continued
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protein (Figure S12A and S12E), including the high-molecular-
weight aggregates speciﬁcally from the insoluble fractions
(Figure S12A and S13), and knockdown of HSPB8 did not affect
this decline (Figure S12E). Taken together, these data indicate
that TFEB drives removal of CryABR120G protein aggregates via
induction of autophagic ﬂux independent of HSPB8 induction.
Figure 5. Adeno-associated virus (AAV9)–mediated transcription factor EB (TFEB) transduction rescues cardiomyopathy in aB-
crystallin R120G mutant transgenic mice and promotes removal of protein aggregates. A, Schematic depicting experimental intervention
with AAV9-mediated TFEB transduction (or AAV9–green ﬂuorescent protein [GFP] as control) in Myh6-CryABR120G transgenic mice or
littermate controls. B and C, Representative immunoblots demonstrating expression of TFEB in total protein extracts with quantitation
(C, left) and aB-crystallin (C, right) in hearts from Myh6-CryABR120G transgenic mice or littermate wild-type (WT) mice transduced with
AAV9-TFEB or AAV9-GFP as in A, at 46 weeks of age. N=5 to 7/group. D through H, Representative 2-dimensional–directed M-mode
echocardiograms (D) in Myh6-CryABR120G transgenic mice or littermate WT mice transduced with AAV9-TFEB or AAV9-GFP as in A, at
46 weeks of age, with quantitation of left ventricular end-diastolic diameter (LVEDD; E), left ventricular percentage endocardial fractional
shortening (LV %FS; F), LV mass (G), and heart weight normalized to tibial length (HW/TL; H) in mice treated as in A. N=5 to 8/group. A
total of 1 of 9 AAV9-GFP–injected and 1 of 6 AAV9-TFEB–injected Myh6-CryABR120G transgenic mice died during the study. See
Table S3 for additional echocardiographic data on these mice. I and J, Representative hematoxylin and eosin (H and E; I) and trichrome
(J) stained myocardial sections from mice treated as in A. Arrowheads point to eosinophilic aggregates in I. *P<0.05 by post hoc test
after 1-way ANOVA.
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TFEB Induces Normalization of Desmin
Expression, Preserves Mitochondrial Polarization,
and Attenuates Cell Death in Cardiomyocytes via
HSPB8 Induction
We next evaluated the effect of TFEB on desmin localization in
NRCMs, cultured to induce sarcomere formation, which
resulted in desmin localization to the Z-discs (see arrows in
groups in top row, in Figure 7A). Adenoviral expression of
CryABR120G induced formation of aggregates and relocaliza-
tion of desmin from the Z-discs to aggregates (see single
arrows in second row, Figure 7A). Overexpression of TFEB
resulted in marked reduction of protein aggregates and
reappearance of desmin at the Z-discs (third row, Figure 7A).
Remarkably, concomitant knockdown of HSPB8 completely
prevented TFEB-induced relocalization of desmin to the Z-
discs, without affecting TFEB-induced reduction of aggregates
in cardiomyocytes expressing CryABR120G (bottom row,
Figure 7A). To conﬁrm the presence of protein aggregates
and their removal by TFEB expression, we evaluated the
localization of p62, an adaptor protein that binds to ubiqui-
tinated proteins to facilitate aggregate formation. Both aB-
crystallin and desmin colocalized with p62 and ubiquitin in
puncta in CryABR120G-transduced cardiac myocytes (see
single arrows, second row, Figure 7B), and desmin was no
longer localized to Z-discs, as observed in controls (arrows in
groups, top row, Figure 7B). TFEB transduction in
CryABR120G-expressing cardiac myocytes resulted in
removal of p62 and ubiquitin-positive aggregates in an
HSPB8-independent manner and normalization of desmin
localization in an HSPB-dependent manner (compare third and
fourth rows, Figure 7B). Given the recently elucidated role for
Z-disc–associated desmin as a scaffold for mitochondria and
maintaining their polarization,37 we examined the effect of
TFEB in CryABR120G-transduced cells on mitochondrial
membrane potential assessed with a ratiometric dye, JC-1.
Cells transduced with CryABR120G demonstrated a marked
increase in prevalence of depolarized mitochondria (Figure 7C
and 7D), as well as increase in mitochondrial DNA content
compared with controls (Figure 7E), indicating accumulation
of damaged mitochondria in the setting of impaired
autophagic ﬂux (Figure S12A, S12C, and S12D). This was
accompanied by increased cell death (Figure 7F), as
described previously.37 Concomitant TFEB transduction
markedly attenuated the CryABR120G-induced increase in
mitochondrial depolarization (Figure 7C and 7D) and reduced
mitochondrial DNA content (Figure 7E), indicating removal of
damaged mitochondria by TFEB-induced restoration of
autophagic ﬂux in this setting (Figure S12A, S12C, and
S12D). This was accompanied by a reduction in cell death
(Figure 7F), in an HSPB8-dependent manner. Intriguingly,
shRNA-mediated HSPB8 knockdown was sufﬁcient to mod-
estly increase the prevalence of depolarized mitochondria and
cell death, suggesting that it plays a critical role in cardiac
myocytes, in vitro, in a resting state. These ﬁndings indicate
that TFEB activation drives normalization of desmin localiza-
tion via both autophagy-dependent and autophagy-indepen-
dent (HSPB8-mediated) mechanisms, thereby preserving
mitochondrial quality and cell viability as the likely mechanism
in the attenuation of CryABR120G-induced cardiomyopathy.
Figure 5. Continued
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TFEB and HSPB8 Are Essential for IF-Mediated
Attenuation of Cardiomyopathy in CryABR120G
Transgenic Mice
To determine the mechanistic role of TFEB and HSPB8 in the
beneﬁcial response to IF, we transduced 36-week-old mice with
AAV9 particles encoding shRNA constructs targeting TFEB and
HSPB8 or a nontargeting scrambled control. Baseline echocar-
diography was performed after 4 weeks, and mice were
subjected to IF with repeated echocardiographic evaluation 3
and 6 weeks later, followed by postmortem analysis (Fig-
ure S13A). Viral transduction with the shRNA constructs results
in 65% reduction in TFEB protein expression (with reduced
levels of nuclear TFEB, Figure S14) and 70% reduction in
Figure 6. Adeno-associated virus (AAV9)–mediated transcription factor EB (TFEB) transduction restores
normal desmin localization in aB-crystallin R120G mutant transgenic mice with upregulation of HSPB8.
A, Representative images demonstrating immunolocalization of desmin (pseudocolored green) in 46-week-
old Myh6-CryABR120G transgenic mice or littermate controls transduced with AAV9-TFEB or AAV9–green
ﬂuorescent protein (GFP) for 10 weeks. White arrowheads point to nuclear TFEB; white arrows in groups
point to desmin associated with Z-discs; single white arrows point to desmin associated with intercalated
discs. B through E, Representative immunoblot (B) with quantitation of HSPB8 (C), HSPB1 (D), and desmin
(E) in total cardiac protein extracts from mice treated as in A. N=3 to 7/group. F, Immunoblot
demonstrating interaction of desmin with HSPB8 and aB-crystallin in Myh6-CryABR120G transgenic mice
subjected to intermittent fasting (IF) or ad-lib (AL) feeding and littermate control hearts (depicted as “-”).
Total protein (1 mg) from cardiac extracts was subjected to immunoprecipitation (IP) with anti-desmin
antibody or control IgG, followed by immunoblotting for HSPB8 and aB-crystallin. At the exposure shown to
demonstrate desmin in transgenic samples, a desmin signal was not evident in wild-type (WT) hearts in the
input lane (with 20 µg/sample) and was seen with longer exposure times (data not shown). G, Immunoblot
demonstrating interaction of desmin with HSPB8 and aB-crystallin in Myh6-CryABR120G transgenic hearts
treated with AAV9-GFP or AAV9-TFEB and subject to immunoprecipitation with anti-desmin antibody (or IgG
as control), as in G. For aB-crystallin, both dark (top) and light (bottom) exposures are shown for F and G.
*P<0.05 by post hoc test after 1-way ANOVA.
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HSPB8 protein compared with the control (Figure 8A through
8C). Interestingly, basal HSPB8 levels were also signiﬁcantly
reduced in AAV9–short hairpin TFEB (shTFEB) treated samples
(compared with controls), conﬁrming that HSPB8 is a TFEB
target, in vivo (Figure 8A and 8C). We did not observe an effect
of TFEB and HSPB8 knockdown on cardiac structure and
function in the Myh6-CryABR120G mice at 4 weeks after AAV
injections to transduce shRNAs targeting TFEB and HSPB8
compared with control shRNA during a period of ad-lib feeding
(Figure 8D, Table S4). IF resulted in statistically signiﬁcant
improvement in LV ejection performance (LV percentage
fractional shortening, Figure 8D, Table S4) in the Myh6-
CryABR120G mice transduced with the control shRNA and
abrogation of LV dilation (Figure S14B, Table S4), similar to prior
observations with IF in non–AAV9-transduced mice (Fig-
ure 4C). By contrast, mice transduced with AAV9-shTFEB as
well as with AAV9–short hairpin HSPB8 (shHSPB8) did not
demonstrate abrogation of progressive dilation and decline in
LV systolic function compared with baseline, despite undergo-
ing IF (Figure 8D, Figure S14B, Table S4). There was no change
in body weight within any treatment group over this period
(Figure S14C, Table S4). As observed in non–AAV9-treated
group (Figure 4F through 4H), IF resulted in reduced eosino-
philic aggregates and ﬁbrosis as well as restoration of desmin
localization in Myh6-CryABR120G mice treated with AAV9–
short hairpin control (Figure 8E through 8G). By contrast,
AAV9-shTFEB and AAV9-shHSPB8 transduced Myh6-
CryABR120G transgenic mice showed increased aggregate
pathologic features and ﬁbrosis as well as persistent abnormal
desmin localization away from Z-discs and intercalated discs,
and in the aggregates, despite IF (Figure 8E through 8G).
Quantitation of aggregates revealed a signiﬁcantly increased
aggregate load in both shTFEB- and shHSPB8-transduced
groups compared with short hairpin control (Figure S15A) and
increased abundance of aB-crystallin, including the higher-
molecular-weight forms in shTFEB- and shHSPB8- versus short
hairpin control–transduced myocardium (Figure S15B). Inter-
estingly, shHSPB8 transduction appeared to partially affect
autophagic ﬂux, which appeared preserved in short hairpin
control group and abrogated with shTFEB transduction in
intermittently fasted Myh6-CryABR120G transgenic mice (Fig-
ure S14D), indicating a role for HSPB8 in facilitating autophagic
ﬂux, in vivo, over a prolonged duration of observation. Taken
together, these data indicate IF beneﬁts require both TFEB and
HSPB8 in the setting of advanced aB-crystallin R120G muta-
tion-induced cardiomyopathy, consistent with the observation
that TFEB activation is sufﬁcient, per se, in transducing these
beneﬁts via mechanisms dependent on autophagy and HSPB8
induction.
Discussion
Myoﬁbrillar cardiomyopathies such as observed with autoso-
mal dominant inheritance of the R120G aB-crystallin mutant
protein increase mortality and morbidity attributable to heart
failure, necessitating development of therapeutic approaches
targeting speciﬁc pathobiologic mechanisms.2 Although prior
studies have examined the efﬁcacy of interventions to prevent
and/or delay the onset of cardiomyopathy,15,33,38 the current
study is the ﬁrst to demonstrate rescue of advanced
cardiomyopathy at a preterminal stage characterized by signs
of heart failure.7,8 Furthermore, we establish IF and TFEB-gene
Figure 6. Continued
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Figure 7. Transcription factor EB (TFEB) normalizes desmin localization via HSPB8 and promotes aggregate removal independent of
HSPB8 expression. A, Representative confocal images demonstrating immunolocalization of desmin and aB-crystallin in neonatal rat
cardiac myocytes (NRCMs) adenovirally transduced with TFEB or control, with and without simultaneous knockdown of HSPB8 (ie,
treated with adenoviral particles coding for R120G mutant of aB-crystallin [multiplicity of infection {MOI}=10; for 48 hours] without or
with HA-tagged TFEB [MOI=10; for 24 hours] in the presence of adenoviral particles expressing short hairpin RNA targeting rat HSPB8
[short hairpin HSPB8 {shHSPB8}; MOI=100; for 72 hours]). Adenoviral particles coding for LacZ or short hairpin LacZ were added as
controls simultaneously with Ad-TFEB or Ad–aB-crystallin overexpression and shHSPB8, respectively, to equalize the number of viral
particles. Arrows point to desmin in Z-discs, and arrowheads point to desmin colocalized with aB-crystallin in aggregates. Representative
of n=2 experiments. B, Representative confocal images demonstrating expression of desmin, ubiquitin, and p62 in NRCMs treated as in
A. Arrows point to desmin in Z-discs, and arrowheads point to desmin colocalized with p62 and ubiquitin in aggregates. Representative
of n=2 experiments. C and D, Representative ﬂow cytometric tracings demonstrating JC-1 ﬂuorescence (C) and quantitation of cells
predominantly expressing JC-1 monomers (lower right quadrants in C; D) for NRCMs treated as described for A. N=7/group.
E, Mitochondrial DNA content indexed to nuclear DNA in cells treated as in A. N=4/group. F, Cell death in NRCMs treated as in A. N=7
to 8/group. *P<0.05 by post hoc test after 1-way ANOVA.
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Figure 8. Knockdown of transcription factor EB (TFEB) and HSPB8 prevents intermittent fasting (IF)–
mediated attenuation of proteotoxic cardiomyopathy with persistent desmin localization to aggregates. A
through C, Representative immunoblot (A) with quantitation of TFEB expression (B) and HSPB8 abundance
(C) in total cardiac protein extracts from Myh6-CryABR120G transgenic mice transduced with adeno-
associated virus (AAV9)–short hairpin control (shCon), AAV9–short hairpin TFEB (shTFEB), or AAV9–short
hairpin HSPB8 (shHSPB8) and subjected to IF, assessed at 46 weeks of age. N=4/group. *P<0.05 by
post hoc test after 1-way ANOVA. Please see schematic in Figure S12A for experimental design. D, Left
ventricular percentage endocardial fractional shortening (LV %FS) in mice treated as in A and evaluated by
echocardiography at baseline (4 weeks after injection of AAV9 particles and before IF, time=0 weeks) and
3 weeks and 6 weeks after initiating IF. N=4 to 5/group. *P<0.05 by post hoc test after 2-way ANOVA.
We did not observe mortality in these treatment groups. See Table S4 for additional echocardiographic
data on these mice. E through G, Representative images demonstrating myocardial sections stained with
hematoxylin-eosin (H and E; E) and Masson’s trichrome (F) and immunostained for desmin expression (G)
in mice treated as in A. In G, white arrows in groups point to Z-discs and arrowheads indicate intercalated
discs to demonstrate desmin localization. Single long white arrows point to desmin localized in
aggregates. H, Schematic depicting the mechanisms by which IF beneﬁts advanced cardiomyopathy
triggered by aB-crystallin R120G mutation. Mutant R120G crystallin expression drives mammalian target
of rapamycin (mTOR) activation with suppressed autophagic ﬂux and aggregates sequestering desmin
within the aggregates, thereby provoking mitochondrial abnormalities and cell death. IF suppresses mTOR
activation, which activates TFEB to stimulate lysosome biogenesis and restores autophagic ﬂux to remove
mutant crystallin aggregates and relieve desmin sequestration. TFEB activation also stimulates HSPB8
expression, which chaperones desmin to its normal localization and restores mitochondrial quality to
rescue cell death.
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therapy as promising strategies that merit exploration as
therapies to treat human cardiomyopathy, resulting from this
mutation. Expression of the human CryABR120G protein in
cardiomyocytes impairs TFEB activation with marked impair-
ment of autophagic ﬂux. In contrast, IF and TFEB activation
restore autophagic ﬂux to remove protein aggregates, and
simultaneously drive transcriptional upregulation of HSPB8,
which binds to desmin and facilitates its physiologic localiza-
tion to the intercalated discs and Z-lines (Figure 8H). This
results in attenuation of cardiomyopathy.
Contemporary literature has fostered a paradigm shift in
understanding the role of lysosomes as active cellular
managers that drive catabolism via autophagy and other
degradative pathways and couple substrate supply to intracel-
lular metabolism.39 In contrast to the increased autophagic ﬂux
observed at early stages of the disease,7 we observe decreased
autophagic ﬂux accompanying advanced CryABR120G-induced
cardiomyopathy. More important, although our experiments
may have been underpowered to detect a difference between
completely impaired versus reduced autophagic ﬂux in
CryABR120G mice at this advanced stage of cardiomyopathy,
our results point to insufﬁcient lysosome function in the setting
of advanced protein aggregate pathologic features. Conceiv-
ably, the long-term increase in protein turnover upregulates
amino acid availability, mimicking an “overfed” state, which
drives an increase mTOR complex 1 activity.40 This results in
phosphorylation and cytosolic sequestration of TFEB, the
master regulator of the autophagy-lysosome machinery,25 with
suppression of autophagic ﬂux. Conversely, when these mice
are subjected to nutrient deprivation by IF, this effect is
overcome to inhibit mTOR complex 1 activity, resulting in TFEB
activation.26 These effects are independent on an effect on
Figure 8. Continued
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body weight, which is not affected by IF in mice on standard
chow26 (Figure S14C) and therefore points to tissue-speciﬁc
signaling effects. Although prior studies have examined the
notion that TFEB stimulates autophagic ﬂux to remove R120G
mutant of aB-crystallin,34 our data set is the ﬁrst to compre-
hensively examine a clinically relevant paradigm for TFEB
activation in vivo and explore relevant mechanisms. Intrigu-
ingly, TFEB transduction was sufﬁcient to drive protein-
aggregate removal via enhancing autophagic ﬂux and restore
normal desmin localization via HSPB8 induction, pointing to a
broader role for the postlysosomal TFEB-mediated transcrip-
tional program in facilitating protein quality control in car-
diomyocytes. Furthermore, our data demonstrate that TFEB
and HSPB8 play a critical mechanistic role in the IF-mediated
rescue of cardiomyopathy and normalization of desmin local-
ization. Whether the activation of TFEB prevents the develop-
ment and progression of cardiomyopathy in this model remains
to be explored.
Our studies suggest a model in which the relative
abundance and competitive-binding afﬁnities of CryABR120G
and HSPB8 proteins to desmin dictate where desmin is
localized to within the cardiomyocyte. Accordingly, in Myh6-
CryABR120G hearts, despite a compensatory transcriptional
upregulation of desmin protein levels, a large fraction of
desmin is bound to the mutant aB-crystallin protein, thus
localizing to aggregates rather than in association with the
Z-discs and intercalated discs. In contrast, the fraction of
desmin bound to HSPB8 dramatically increases with a
concomitant decline in mutant aB-crystallin binding with IF
and TFEB transduction, a scenario that favors physiologic
desmin localization with attenuation of cardiomyopathic
manifestations. Although we have not directly examined
desmin degradation rates in vivo, our data demonstrating a
lack of effect of IF on desmin transcripts, protein, and
ubiquitination state support this model.
Prior studies have shown that CryABR120G protein
aggregates into amyloid oligomers,41 a process that can be
prevented by overexpression of the chaperones, HSPB8
(HSP22) and HSPB1 (HSP25)12; and transgenic expression
of HSPB8 in cardiomyocytes prevents development of amyloid
oligomers and cardiomyopathy.35 Our observations suggest
that the desmin bound to the mutant crystallin protein is
released on TFEB-induced protein-aggregate removal in the
Myh6-CryABR120G hearts and is chaperoned by HSPB8 to its
normal localization. Intriguingly, induction of HSPB8 promotes
autophagic clearance of aggregate-prone proteins, such as
mutant SOD1 (superoxide dismutase 1) and TDP43 (TAR DNA-
binding protein 43) (implicated in amyotrophic lateral sclero-
sis) and polyglutamine repeat-bearing mutant androgen
receptor (in spinal bulbar atrophy),42,43 and mutations in
HSPB8 implicated in causing Charcot Marie tooth disease and
distal hereditary motor neuropathy 2A impair autophagosome
maturation in neuronal cell types.44 Our ﬁndings demonstrate
that shRNA-mediated knockdown of HSPB8 had a modest
effect on autophagic ﬂux and autophagic clearance of aB-
crystallin aggregates, in vivo; and HSPB8 expression was
essential to restore desmin localization with TFEB expression
in CryABR120G-expressing cardiomyocytes.
Normal localization of desmin in association with the
Z-discs and intercalated discs plays a critical scaffolding role
in maintaining mitochondrial polarization and function18,37
and sarcomere integrity.19 Mutations in the desmin tail that
selectively impair its localization to the Z-disc45 cause
cardiomyopathy in humans,46 whereas experimental ablation
of desmin in mice induces sarcomeric degeneration19 and a
dilated cardiomyopathy with systolic dysfunction.20 Similarly,
both missense mutations in desmin47 as well as a 7–amino
acid deletion48 that impairs desmin assembly into intermedi-
ate ﬁlaments are sufﬁcient to provoke an autosomal-dominant
cardiomyopathy in humans.47,48 Reexpression of desmin via
AAV9 transduction restored cardiac function and attenuated
cardiomyopathy in desmin null mice.49 Indeed, the dominant-
negative effect of CryABR120G protein may be to sequester
desmin (and other sarcomeric proteins and chaperones) away
from their physiologic intracellular localization sites.
Reduced myocardial cell death and ﬁbrosis with IF and
TFEB activation, in vivo, are consistent with the restoration of
polarized mitochondria and attenuated cell death with TFEB
expression in CryABR120G-expressing cardiomyocytes, in
in vitro studies. Indeed, mitochondrial abnormalities are
observed in the desmin null myocardium as well as
CryABR120G transgenic hearts, that result in mitochondrial
permeabilization and cell death,9,33 which could be rescued by
overexpression of an antiapoptotic protein, Bcl2.10,50 Our data
suggest that IF or TFEB-induced normalization of desmin
localization attenuates mitochondrial abnormalities as the
proximate mechanism for attenuation of cardiomyopathy.
Moreover, we have demonstrated that TFEB activation facil-
itates mitochondrial quality control via coordinated removal of
damaged mitochondria and biogenesis of normal mitochon-
dria under stress in cardiomyocytes, and this mechanism also
needs to be formally evaluated in future studies.28
Our key ﬁnding, that IF and TFEB activation were sufﬁcient to
rescue established cardiomyopathy despite the markedly
increased cell death9 and ﬁbrosis7,15 seen at this advanced
stage of pathogenesis,8 underscores the potential for restoring
desmin to favorably remodel sarcomere in failing cardiomy-
ocytes to treat desmin-related cardiomyopathies.2 Further-
more, this paradigm may also be broadly relevant to
cardiomyopathy and heart failure of diverse causes, in which
abnormal desmin localization and protein aggregation are
observed, such as in hearts from patients with hypertrophic
cardiomyopathy with reduced VPS34 expression51 and from
patients with dilated cardiomyopathy.41,52,53 More important,
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these observations raise hopes for a therapeutic strategy
targeting TFEB activation to slow or reverse disease pathogen-
esis, at a clinically relevant stage when most patients receive
their initial diagnosis; and set the stage for experimental
evaluation of therapies such as trehalose, a safe nonreducing
disaccharide,39 or small molecules targeting mTOR25 that
activate TFEB.
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Fasting studies in mice: Mice were housed in groups of up to n = 5 mice/cage and fed standard chow (Lab 
Diet, 5053; providing 3.4 Kcal/g with 62.1% Kcal derived from carbohydrates, 13.2% from fats, and 
24.6% from protein) on a 6:00 PM to 6:00 AM dark-light cycle. Intermittent fasting was performed with 
total food deprivation and ad libitum access to water while mice were housed on a cedar pine chip 
bedding from 12:00 PM to 12:00 PM of the following day to implement alternate periods of 24 h fasting 
and feeding, with change in bedding (AL indicates fed ad libitum and IF indicates that animals were 
provided access to food every other day).1 Non-fasted control mice were simultaneously provided fresh 
food with change in bedding. Terminal studies on mice were initiated between 8:00 to 10:00 AM after an 
overnight period of feeding (i.e., on a fed day).  For fasting studies to determine the effects on HSPB8 
transcript levels in the heart, mice were fasted for various durations beginning at 6:00 PM (the onset of 
the dark cycle during which mice typically feed). 
Echocardiography: Echocardiography was performed using a Vevo 2100 Imaging System (VisualSonics, 
Toronto, Canada) equipped with a 30 MHz linear-array transducer according slight modifications of 
previously published methods.2, 3 Briefly, mice were anesthetized using 0.1 g/kg IP Avertin (2,2,2-
Tribromoethanol, Sigma-Aldrich, St. Louis, MO). Cardiac images were obtained by a handheld 
technique. Parasternal long- and short-axis images of the LV were used to guide acquisition of M-mode 
images at the papillary muscle level. Digitally recorded images were used to measure LV wall thickness 
(LV posterior wall, LVPW; interventricular septum, IVS) and chamber diameter (LVEDD) in end-
diastole (d) and in end-systole (s). These measurements were used to calculate LV fractional shortening 
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Studies with neonatal rat cardiac myocytes (NRCMs): Primary cultures of neonatal rat cardiac myocytes 
were prepared as we have previously described.4 Hearts were harvested from one-day old neonatal rats, 
and the ventricles were subjected to trypsin (Invitrogen) digestion in a final concentration of 100 μg/ml in 
HBSS for 16 – 18 hours at 4°C after removal of the atria. Collagenase digestion (type II collagenase; 150 
U/ml; Worthington) was conducted at 37 ° C for 45 min. The mixture of cells was plated for 2 h in flasks 
to exclude fibroblasts. The remaining non-adherent cardiomyocytes were seeded on collagen-coated four-
well chamber slides (Laboratory Tek) at a density of 105 cells per square cm. On the 2nd day the culture 
medium was changed to the Rat Cardiomyocyte Culture Medium (Cell applications INC, cat#R313-500) 
for at 3-5 days prior to desmin staining. NRCMs were treated with Bafilomycin A1 (BfA, Fisher 
scientific, cat#NC9686929): 200nM for 2 hours prior to harvest to assess autophagic flux, in vitro. 
Isolation of soluble and insoluble fractions: The protocol described by Tannous et al was modified for 
this assay.5 Heart tissue was mechanically homogenized in 500-1000ul (depending on size of tissue) of 
homogenization buffer (0.3 M KCl, 0.1 M KH2PO4, 50 mM K2HPO4, 10 mM EDTA, 4 mM Na 
Orthovanadate, 100 mM NaF, Protease inhibitor, pH to 6.5). NRCMs were similarly homogenized with 
20 strokes on ice with a Dounce homogenizer. Homogenized samples were passed through mesh basket 
on ice, followed by collection of the lysate run-through which was incubated on ice for 30 minutes. A 
known volume of the sample was transferred to another Eppendorf tube and 10% NP-40 was added to for 
a final concentration of 1% NP-40. Samples were then incubated on ice for 30 minutes, and spun at 
13,000 rpm for 15 minutes, 4°C. Supernatant was collected as soluble fraction. The pellet was washed 3 
times with cold PBS (following addition of 1ml PBS to each pellet, and spin down at 13,000 rpm for 10 
minutes) followed by resuspension in 1% SDS, 10mM Tris buffer to generate the insoluble fraction. 
Quantitation of desmin in aggregates by immuno-fluoressence: At least 10 images were obtained per 
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zoom factor using a Zeiss Fluorescent microscope. After acquisition, images were converted into a JPG 
format using the Zeiss Zen software. Each image was analyzed using ImageJ software with a 
predetermined size threshold to exclude noise to obtain area of aggregates per section, depicted as a 
percentage of the total visualized area. 
Puromycin labeling to assess protein synthesis by the SunSET technique: We utilized the SunSET 
technique to assess protein synthesis in the mouse heart.6 Mice were injected with puromycin (Enzo Life 
Sciences, Inc. cat#BML-GR312-0250) at a dose of 0.04 μmol/g body mass, i.p. 30 minutes prior to 
sacrifice. Cardiac tissue was homogenized in buffer I (50mM Tris HCl pH7.4, 2.5mM EDTA, 25mM 
NaCl, 0.2% NP 40, 10mM EGTA, 20mM NaFl, 25mM Na4O7P2, 2mM Na3VO4 with added Halt 
Protease and Phosphatase InhibitorTM, Thermo Scientific, cat# 78442) and subjected to SDS-PAGE 
electrophoresis. Anti-puromycin antibody (clone 12D10, cat# MABE343 from Millipore) was employed 
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Table S1. List of primers for quantitative PCR analysis. 
Rat Genes Forward (5’-3’) Reverse (5’-3’) 
HSP90aa1 GCTTTCAGAGCTGTTGAGATAC AAAGGCTGAGTTAGCAACCTGG 
HSPB1 CGGCAACTCAGCAGCGGTGTCT CATGTTCATCCTGCCTTTCTTCGTG 
HSPB8 CCGGAAGAACTGATGGTAAAGAC CCTCTGGAGAAAGTGAGGCAAATAC 
CryAB CTTCTACCTTCGGCCACCCTC GCACCTCAATCACGTCTCCC 
HSPBAP1 GTACATTGTGGATCGGATCCCT GGAAAGGTGTATCTTCAGGAGG 
HSP70 ACGAGGGTCTCAAGGGCAAG CTCTTTCTCAGCCAGCGTGTTAG 
RPL32 CCTCTGGTGAAGCCCAAGATC TCTGGGTTTCCGCCAGTTT 
Mouse Genes Forward (5’-3’) Reverse (5’-3’) 
Desmin GCGGCTAAGAACATCTCTGAGG ATCTCGCAGGTGTAGGACTGGA 
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Table S2. Evaluation of cardiac function by m-mode echocardiography in wild type ad lib fed mice and Myh6CryaABR120G mice -  either treated with 
ad lib feeding or intermittent fasting. Data shown is Mean ± SEM. 
* indicates p<0.05 by post-hoc testing after one way ANOVA vs. wild-type control.
# indicates p<0.05 by post-hoc testing after one way ANOVA for Myh6CryABR120G IF vs. ad-lib.
LVEDD = left ventricular end-diastolic dimension. LVESD = left ventricular end-systolic dimension. FS = fractional shortening. IVSd = diastolic thickness of the 








LVEDD (mm) 3.3 ± 0.1 4.2 ± 0.1* 3.7 ± 0.1*# 
LVESD (mm) 1.7 ± 0.1 3.2 ± 0.1* 2.5 ± 0.2*# 
FS (%) 49.6 ± 2.2 24.1 ± 1.5* 32.6 ± 3.9*# 
IVSd (mm) 0.70 ± 0.04 1.01 ± 0.06* 0.92 ± 0.03* 
PWTd (mm) 0.71 ± 0.03 0.85 ± 0.03* 0.81 ± 0.03* 
LVM (mg) 70 ± 5 152 ± 8* 114 ± 3*# 
r/h 2.3 ± 0.2 2.3 ± 0.1 2.2 ± 0.1 
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Table S3. Evaluation of cardiac function by M-mode echocardiography in wild type mice and Myh6CryaABR120G mice treated with AAV9-GFP or 








compared to respective AAV-GFP treated Wild type control group. 
# indicates p<0.05 by post-hoc testing after one way ANOVA AAV9-TFEB-treated vs. AAV9-GFP-treated Myh6CryABR120G TG mice. 
LVEDD = left ventricular end-diastolic dimension. LVESD = left ventricular end-systolic dimension. FS = fractional shortening. IVSd = diastolic thickness of the 














LVEDD (mm) 3.3 ± 0.1 3.2 ± 0.1 4.2 ± 0.1* 3.9 ± 0.1* 
LVESD (mm) 1.8 ± 0.1 1.8 ± 0.1 3.5 ± 0.1* 2.8 ± 0.1*# 
FS (%) 46.8 ± 1.3 45.8 ± 2.7 15.3 ± 1.4* 28.1 ± 2.0*# 
IVSd (mm) 0.93 ± 0.04 0.97 ± 0.01 1.08 ± 0.02* 1.00 ± 0.05 
PWTd (mm) 0.8 ± 0.02 0.93 ± 0.04 0.96 ± 0.02* 0.89 ± 0.03 
LVM (mg) 97 ± 3 106 ± 2 172 ± 6* 141 ± 6*# 
r/h 1.9 ± 0.1 1.7 ± 0.1 2.0 ± 0.1 2.1 ± 0.1 
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Table S4. Evaluation of cardiac function by M-mode echocardiography in Myh6CryaABR120G mice treated with AAV9 control, AAV9 shTFEB, or 
AAV9shHspB8 and subjected to intermittent fasting (IF). The data are presented at T0 (prior to initiation of IF at 4 weeks post AAV injection), T3 (3 weeks 
after initiation of IF) and T6 (6 weeks after IF). All data are shown as Mean ± SEM. 
@ indicates p<0.05 by post-hoc testing after 2-way ANOVA for comparison of AAV9-shControl at the T6 timepoint as compared to baseline (T0). 
* indicates p<0.05 by post-hoc testing after 2-way ANOVA for comparison of AAV9-shTFEB/shHspB8 groups vs. AAV9-shControl at the same time point.
$ indicates p = 0.06 by post-hoc testing after 2-way ANOVA for comparison of AAV9-shTFEB vs. AAV9-shControl at the same time point.











T0 T3 T6 T0 T3 T6 T0 T3 T6 
LVEDD (mm) 4.4 ± 0.2 4.4 ± 0.2 4.3 ± 0.2 4.2 ± 0.1 4.6 ± 0.1 4.6 ± 0.1 4.4 ± 0.3 4.7 ± 0.2 4.7 ± 0.1 
LVESD (mm) 3.3 ± 0.3 3.2 ± 0.3 2.9 ± 0.2 3.2 ± 0.1 3.4 ± 0.11 3.5 ± 0.13$ 3.4 ± 0.3 3.8 ± 0.3* 3.8 ± 0.2* 
FS (%) 25.9 ± 3.3 28.1± 3.8 33.7 ± 2.0@ 25.2 ± 1.1 25.1 ± 1.1 24.4 ± 0.3* 22.7 ± 2.9 19.0 ± 3.2* 19.6 ± 1.9* 
IVSd (mm) 0.8 ± 0.04 0.8 ± 0.02 0.8 ± 0.02 0.8 ± 0.01 0.8 ± 0.02 0.8 ± 0.02 0.8 ± 0.02 0.8 ± 0.02 0.8 ± 0.04 
PWTd (mm) 0.7 ± 0.02 0.7 ± 0.01 0.7 ± 0.02 0.7 ± 0.01 0.7 ± 0.02 0.7 ± 0.01 0.7 ± 0.01 0.7 ± 0.01 0.7 ± 0.03 
LVM (mg) 125 ± 15 120 ± 10 114 ± 6 111 ± 6 127± 6 125 ± 6 127 ± 14 144 ± 13 133 ± 10 
r/h 3.1 ± 0.1 3.0 ± 0.1 3.0 ± 0.1 3.0 ± 0.1 3.1 ± 0.1 3.2 ± 0.1 2.9 ± 0.2 3.1 ± 0.1 3.3 ± 0.2 
HR 
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Figure 51. Autophagic flux assessment reveals preserved autophagic flux in skeletal muscle from Myh6-
R120G aB-Crystallin TG mice and in the transgenic mouse hearts at a young age. A) lmmuno-blot 
demonstrating LC3 and p62 expression in heart and skeletal muscle (gastrocnemius) tissue from 40 week old 
Myh6-R120G aB-Crystallin TG mice treated with CQ or diluent for autophagic flux assessment 
(representative of n=2 experiments). B, C) Representative immuno-blot (B) depicting LC3-II and p62 expression 
with quantitation (C) in young (8 week) Myh6-R120G aB-Crystallin TG mice treated with CQ or diluent for 
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aB-Crystallin 










Figure 52. Expression of aB-Crystallin in Myh6-R120G aB-
C'Y.stallin TG mice and CryAB null mice demonstrates 
specificity for immuno-detection of aB­Crystallin. lmmunoblot 
demonstrating expression of aB-Crystallin in hearts from 
Myh6-R120G aB-Crystallin TG mice, CryAB null mice and 
wild-type controls. Arrows point to various electrophoretic bands 
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Figure 54. Intermittent fasting and TFEB activation
do not alter desmm transcription. A) Transcript abundance for desmin 
in hearts from Myh6-R120G aB-Crystallin TG mice subjected to intermittent 
fasting or ad-lib feeding, and littermate wild-type controls. N=4/group. 
* indicates P<0.05 by post-hoc test after one-way ANOVA. B) Transcript 
abundance for desmin in hearts from Myh6-R120G aB-Crystallin TG mice 
and littermate wild-t pe control mice transduced with AAV-TFEB or AAV-
GFP. N=3-6/group. 
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Figure 55: AAV-mediated TFEB transduction upregulates abundance of candidate autophagy-
lysosome target proteins. A) lmmunoblot depicting nuclear TFEB abudance in cardiac tissue from 
CryABR120G mice transduced with AAV-GFP or AAV-TFEB at 36 weeks of age, and sacrificed 10 weeks 
later. B-F) Representative immuno-blot with quantification of protein 
abundance for LC3-II (C), LAMP1 (D), p62 (E) and LAMP2 (F) in cardiac tissue from wild-type mice 
transduced with AAV-GFP or AAV-TFEB at 36 weeks of age, and sacrificed 10 weeks later. • indicates P 
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Supplementary Figure 56: TFEB transduction does not alter transcript levels of the human CryAB R120G 
transgene and does not affect cardiac protein synthesis. A) Quantitative PCR analysis for detecting human 
CRYAB transgene expression with specific primer set (see Supplementary Table 1) in Myh6-R120G aB-Crystallin 
TG mice transduced with AAV-TFEB or AAV-GFP. N=4/group. 8, C) Wild-type male C57bl6 mice (8 weeks old) 
were transduced with AAV-GFP or AAV-TFEB for 4 weeks and SunSET assay performed for assessing cardiac 
protein synthesis. Representative immuno-blot (B} with quantitation of puromycin incorporation (C) in cardiac 
extracts from a non-injected control mouse and AAV transduced mice. D) Representative immuno-blots for 


































Figure S7. TFEB transduction reduces aggregate pathology and myocardial cell death in Myh6-R120G aB-Crystallin TG 
mice. A) Quantitation of aggregates as% area of the myocaraium in AAV-GFP and AAV-TFEB transduced mice at 46 weeks of age 
(see Figure 6A for images). N=3/grouQ. * indicates P<0.05 by t-test. B, C) Representative TUNEL stained images (with DAPl-stained 
nuclei, B) with quantitation of TUN EL+ nuclei (pseudo-colored green, arrows in C) in hearts from 
My/i6-R120G aB-C_rystallin TG mice and WT controls transduced with AAV9-TFEB or AAV9-GFP for 10 weeks beginning at 36 
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Figure 58. TFEB induces HSPB8 expression. Transcript abundance of 
various heat shock protein family members in NRCMs adenovirally 
transduced with HA-tagged TFEB or Ad-Lacz (MOl=10 each) for 24 hours. 
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Figure 59. Fasting increases HSPB8 transcript and protein levels in the myocardium. A) HSPB8 transcript levels in cardiac tissue from C57bl6 
wild-type mice fasted for various durations as shown. N=4/group. * indicates P<0.05 by post-hoc analysis after one way ANOVA 
B, C) Representative immunoblot (B) and quantitation of HSPB8 protein levels (C) rn the myocardium from fed wild-type mice, mice fasted for 24 
hours, and mice fasted for 24 hours followed by re-feeding for 24 hours. N=3/group.* indicates P<0.05. D, E) Representative immunoblot (D) and 
guantitation of HSPB8 protein levels (E) in the myocardium from Myh6-R120G aB-Crystallin TG mice subjected to intermittent fasting (IF) or ad-lib 
feeding for 6 weeks beginning at 40 weeks of age (see Fig. 2A for schematic) and WT controls (N=4/group). * indicates P<0.05 by post-hoc test 
























Figure 510. R120G mutant CRYAB P.rotein interacts more strongly with desmin 
ttian fhe wild-type CRYAB protein, in vivo. A) Male C57bl6 mice at 8 weeks of age 
were transduced with AAV9 particles with cardiac troRonin T promoter driven expression 
of FLAG-tagged human CRYAB protein or its R120G mutant for 4 weeks. Representative 
immuno-blot demonstratirlQ expression of FLAG-tagged CRYAB proteins is shown in A. 
Mice not treated with AAVg-Rarticles are shown as control; 'ns' indicates non-specific 
band. B) Quantitation of FLAG-tagged CRYAB protein and its R120G mutant in cardiac 
extracts from mice treated as in A. N=3/group. NS indicates not-significant for P value by 
t-test. C) lmmuno-precipitation was performed with anti­FLAG antibody (or lgG confrol) in 
cardiac extracts from mice treated as in A and immuno-blot performed for desmin and 
CRYAB. Representative immuno-blot is shown. D) Quantitation of desmin expression in 
after immuno-precipitation with anti-FLAG antibody as shown in C. N=3/group. * 
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 Figure 511. Intermittent fasting does not alter desmin ubiquitination. 
lmmunoblot demonstrating poly-ubiquitinated desmin in Myh6-CryABR120G TG 
mice subjected to intermittent fasting (IF) or ad-lib (AL) feeding and littermate 
control hearts (depicted as"-"). One mg of total protein from cardiac extracts was 
subjected to immunoprecipitation with anti-desmin antibody or control lgG, followed 
by immuno-blotting for ubiquitin. The immunoblot for desmin is reproduced from 
the blot shown in Figure 6F. At the exposure shown to demonstrate desmin in TG 
samples, a desmin signal was not evident in WT hearts in the input lane (with 20 
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Figure S12. TFEB promotes clearance of aB-crystallin via induction of autophagic flux, 



































































cr�tallin overexpression and sh-HSPB8, respectively...._to equalize the number of viral particles. s.:o) Quantitation of HSPB8 (B), LC3-II (C) and P.62 {!..J). expression in NRCMs treated as in A. 
N=37group. * indicates P<0.05 oy t-test within BfA ana diluent treated QrouP,s; and # indicates 
P<0.05 QY post-hoc test after one-way ANOVA for comparisons withinlhe ailuent treated group
only. E) Uuantitation of aB-crystallin expression in the non-Bf A treated samples from A. 
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Figure 513. TFEB promotes removal of aB-Crystallin 
aggregates in NRCMs. lmmunoblot demonstrating aB-
Crystallin expression in soluble and insoluble fractions 
from NRCMs adenovirally transduced with R 120G 
mutant of aB-Crystallin (MOl=1 O; for 48 hours) without or 
with HA-tagged TFEB (MOl=1 O; for 24 hours). Adenoviral 
particles coding for Lacz were added as controls 
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Figure S14. Knockdown of TFEB and HSPB8 prevents intermittent fasting-mediated attenuation of proteotoxic 
cardiomyopathy. A) Schematic depicting experimental intervention with AAV9- mediated shRNA transduction 
(directed to either TFEB or HSPB8 vs. control sh RNA) in 36 week old Myh6- CryABR120G TG mice. Four weeks after 
AAV injection, baseline echocardiograms were obtained followed by 
6 weeks of intermittent fasting (termed T=O time point). Serial echocardiograms were then obtained at 3 weeks and 6 
weeks (termed T=3 and T=6 time points, respectively), followed by sacrifice and post mortem biochemical, 
microscopic and immuno-histochemical analysis. B) lmmunoblot depicting levels of nuclear TFEB after transduction 
with shTFEB vs. shCon. C) Left ventricular end-diastolic diameter assessed as fold-change compared to baseline 
(T= 0 weeks) data-point in the control group, in mice treated as in A. N=4-5/group. * indicates P<0.05 by post-hoc 
test after two-way ANOVA. D) Body weight over the duration of the study in mice treated as in A. N=4-5/group. 
* indicates P<0.05 by post-hoc test after two-way ANOVA. D) Representative immuno-blot demonstrating
expression of LC3 and p62 in mice modeled as in A and injected with chloroquine (40 mg/kg) 4 hours prior to 
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Figure 515. Knockdown of TFEB and HSPB8 prevents intermittent fasting-
mediated removal of aggregates with persistent desmin localization to 
aggregates. A) Quantitation of aggregates as % area of the myocardium in Myh6-
CryABR120G TG mice transduced with AAV9-shControl, AAV9-shTFEB or 
AAV9-shHSPB8 for 4 weeks at age of 36 weeks and subjected to intermittent 
fasting, assessed at 46 weeks of age. See Figure 8G for representative images. 
N=3/group. P value is by post-hoc test after one-way ANOVA. B, C) 
Representative immuno-blot (B) with quantitation of aB-crystallin in insoluble (C) 
myocardial fractions from Myh6-CryABR120G TG mice at 46 weeks of age 
injected with AAV9 particles coding for shRNAs targeting TFEB or HSPB8, or 
control for 4 weeks and then subjected to intermittent fasting for 6 weeks. N=3/
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Statistical Values calculated using R code for figure panels labeled as below 
1) Figure 1B:
Exact Permutation Test (complete enumeration) 
data:  WT dil and WT CQ 
p-value = 0.002165
alternative hypothesis: true mean s10 - mean s20 is  0
sample estimates:
mean WT dil - mean WT cq
-0.5683489
data:  CryAB dil and CryAB CQ 
p-value = 0.9524
alternative hypothesis: true mean s11 - mean s21 is  0
sample estimates:
mean CryAB dil - mean CryAB CQ
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2) Figure. 1C:
Exact Permutation Test (complete enumeration) 
data:  WT dil and WT CQ 
p-value = 0.002165
alternative hypothesis: true mean s10 - mean s20 is  0
sample estimates:
mean WT dil - mean WT CQ
-0.5683489
data:  CryAB dil and CryAB CQ 
p-value = 0.9524
alternative hypothesis: true mean s11 - mean s21 is  0
sample estimates:
mean CryAB dil - mean CryAB CQ
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3) Figure. 1D 
  
 
 Exact Permutation Test (complete enumeration) 
 
data:  WT dil and WT CQ 
p-value = 0.002165 
alternative hypothesis: true mean s10 - mean s20 is  0 
sample estimates: 
mean WT dil - mean WT CQ  
         -0.5683489 
 
data:  CryAB dil and CryAB CQ 
p-value = 0.9524 
alternative hypothesis: true mean s11 - mean s21 is  0 
sample estimates: 
mean CryAB dil - mean CryAB CQ  
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4) Figure. 2D 
  
 Exact Permutation Test (complete enumeration) 
 
data:  WT and CryAb  AL 
p-value = 0.02857 
alternative hypothesis: true mean s10 - mean s11 is  0 
sample estimates: 
mean s10 - mean s11  
          0.5142135 
 
data:  Cyto: CryAB AL and CryAB IF 
p-value = 0.08571 
alternative hypothesis: true mean s11 - mean s12 is  0 
sample estimates: 
mean s11 - mean s12  
         -0.2665246 
 
data:  Nuc: CryAB AL and CryAB IF 
p-value = 0.02857 
alternative hypothesis: true mean s21 - mean s22 is  0 
sample estimates: 
mean s21 - mean s22  
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Exact Permutation Test (complete enumeration) 
 
data: LC3-II CryAB R120G IF dil vs. CRYAB R120G IF CQ 
p-value = 0.0079 
alternative hypothesis: true mean s12 - mean s13 is  
sample estimate 
mean s12 - mean s1 
         -0.391546 
 
 
data:  p62 CryAB R120G IF dil vs. CRYAB R120G IF CQ  
p-value = 0.0079 
alternative hypothesis: true mean s22 - mean s23 is  
sample estimate 
mean s22 - mean s2 




 http://ahajournals.org by on March 2, 2019
6) Figure. 2H 
  
Exact Permutation Test (complete enumeration) 
 
data:  LAMP1: WT and CRYAB AL  
p-value = 0.02857 
alternative hypothesis: true mean s10 - mean s11 is  0 
sample estimates: 
mean s10 - mean s11  
          0.3220731 
 
data:  LAMP1: CRYAB AL  and CRYAB IF 
p-value = 0.02857 
alternative hypothesis: true mean s11 - mean s12 is  0 
sample estimates: 
mean s11 - mean s12  
         -0.2118281 
 
data:  LAMP2: WT and CRYAB AL 
p-value = 0.02857 
alternative hypothesis: true mean s20 - mean s21 is  0 
sample estimates: 
mean s20 - mean s21  
          0.3928372 
 
data:  LAMP2: CRYAB AL and CRYAB IF 
p-value = 0.02857 
alternative hypothesis: true mean s21 - mean s22 is  0 
sample estimates: 
mean s21 - mean s22  





 http://ahajournals.org by on March 2, 2019
7) Figure. 2J 
  
 Exact Permutation Test (complete enumeration) 
 
data:  pMTOR/mTOR WT vs. CRYAB AL 
p-value = 0.02857 
alternative hypothesis: true mean s10 - mean s11 is  0 
sample estimates: 
mean s10 - mean s11  
          -1.810188 
 
data:  :  pMTOR/mTOR CRYAB AL vs. CRYAB IF 
p-value = 0.02857 
alternative hypothesis: true mean s11 - mean s12 is  0 
sample estimates: 
mean s11 - mean s12  
          0.9711987  
 
data p-S6K/S6K WT vs. CRYAB AL  
p-value = 0.02857 
alternative hypothesis: true mean s20 - mean s21 is  0 
sample estimates: 
mean s20 - mean s21  
          -1.134393 
 
data:  S6K/S6K CRYAB AL vs. CRYAB IF 
p-value = 0.02857 
alternative hypothesis: true mean s21 - mean s22 is  0 
sample estimates: 
mean s21 - mean s22  
          0.7850461 
 
data:  p-4EBP1/4EBP1 WT vs. CRYAB AL 
p-value = 0.02857 
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sample estimates: 
mean s30 - mean s31  
          -1.134386 
 
data:  p-4EBP1/4EBP1 CRYAB AL vs. CRYAB IF  
p-value = 0.02857 
alternative hypothesis: true mean s31 - mean s32 is  0 
sample estimates: 
mean s31 - mean s32  
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8) Figure. 3B 
  
 
Exact Permutation Test (complete enumeration) 
 
data:  CRYAB AL vs. IF 
p-value = 0.02857 
alternative hypothesis: true mean s1 - mean s2 is  0 
sample estimates: 
mean s1 - mean s2  
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9) Figure. 3C 
  
 
 Exact Permutation Test (complete enumeration) 
 
data:  CRYAB AL vs. IF 
p-value = 0.02857 
alternative hypothesis: true mean s1 - mean s2 is  0 
sample estimates: 
mean s1 - mean s2  
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10) Figure. 4B 
  
 
data:  WTAL vs.  CRYAB AL 
p-value = 0.001263 
alternative hypothesis: true mean s2 - mean s3 is  0 
sample estimates: 
mean s2 - mean s3  
       -0.8959714 
 
data:  CRYAB IF and CRYAB AL 
p-value = 0.006993 
alternative hypothesis: true mean s1 - mean s3 is  0 
sample estimates: 
mean s1 - mean s3  
       -0.4657143  
 
data:  CRYAB IF and WT AL 
p-value = 0.005051 
alternative hypothesis: true mean s1 - mean s2 is  0 
sample estimates: 
mean s1 - mean s2  
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11) Figure. 4C 
 
 
Exact Permutation Test (complete enumeration) 
 
data:  CRYAB AL vs. IF 
  
 
 Exact Permutation Test (complete enumeration) 
 
data:  WTAL vs.  CRYAB AL 
p-value = 0.001263 
alternative hypothesis: true mean s2 - mean s3 is  0 
sample estimates: 
mean s2 - mean s3  
         25.54954  
 
data:  CRYAB IF and CRYAB AL 
p-value = 0.08159 
alternative hypothesis: true mean s1 - mean s3 is  0 
sample estimates: 
mean s1 - mean s3  
         8.524286  
 
 
data:  CRYAB IF and WT AL 
p-value = 0.01136 
alternative hypothesis: true mean s1 - mean s2 is  0 
sample estimates: 
mean s1 - mean s2  
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12) Figure. 4D 
 
 
 Exact Permutation Test (complete enumeration) 
 
data:  CRYAB AL vs. IF 
p-value = 0.001263 
alternative hypothesis: true mean s2 - mean s3 is  0 
sample estimates: 
mean s2 - mean s3  
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 13) Figure. 4E 
 
 
 Exact Permutation Test (complete enumeration) 
 
data:  CRYAB AL vs. IF 
p-value = 0.0001998 
alternative hypothesis: true mean s2 - mean s3 is  0 
sample estimates: 
mean s2 - mean s3  
        -4.391861 
 
data:  CRYAB IF and CRYAB AL 
p-value = 0.01132 
alternative hypothesis: true mean s1 - mean s3 is  0 
sample estimates: 
mean s1 - mean s3  
        -1.983246 
 
 
data:  CRYAB IF and WT AL 
p-value = 4.114e-05 
alternative hypothesis: true mean s1 - mean s2 is  0 
sample estimates: 
mean s1 - mean s2  
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 Exact Permutation Test (complete enumeration) 
 
data:  TFEB WT AAV GFP and WT AAV TFEB 
p-value = 0.004329 
alternative hypothesis: true mean s2 - mean s3 is  0 
sample estimates: 
mean s2 - mean s3  
        0.9304463 
 
 
data:  TFEB CRYAB AAV GFP and CRYAB AAV TFEB 
p-value = 0.0005828 
alternative hypothesis: true mean s1 - mean s4 is  0 
sample estimates: 
mean s1 - mean s4  
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data:  Crystallin WT AAV GFP and WT AAV TFEB 
p-value = 0.002165 
alternative hypothesis: true mean s2 - mean s3 is  0 
sample estimates: 
mean s2 - mean s3  
        0.9835765 
 
 
data:  Crystallin WT AAV GFP and CRYAB AAV TFEB  
p-value = 0.002165 
alternative hypothesis: true mean s2 - mean s4 is  0 
sample estimates: 
mean s2 - mean s4  
        -17.61125  
 
data:  Crystallin CRYAB AAV GFP and CRYAB AAV TFEB 
p-value = 0.0005828 
alternative hypothesis: true mean s1 - mean s4 is  sample estimates: 
mean s1 - mean s4  
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Exact Permutation Test (complete enumeration) 
 
 data:  WT + AAV GFP VS. CRYAB R120 + AAV GFP 
p-value = 0.000777 
alternative hypothesis: true mean s3 - mean s4 is  0 
sample estimates: 
mean s3 - mean s4  
          -0.8395 
 
data:  CRYABR120G + AAV GFP VS. CRYAB R120 + AAV TFEB 
p-value = 0.1593 
alternative hypothesis: true mean s1 - mean s4 is  0 
sample estimates: 
mean s1 - mean s4  
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16) Figure. 5F 
  
 
 Exact Permutation Test (complete enumeration) 
 
data:  CRYAB R120G AAV GFP VS. CRYABR120G AAV TFEB 
p-value = 0.001554 
alternative hypothesis: true mean s1 - mean s4 is  0 
sample estimates: 
mean s1 - mean s4  
         12.76925  
 
data:  CRYABR120G AAV TFEB and WT AAV9 GFP 
p-value = 0.007937 
alternative hypothesis: true mean s1 - mean s3 is  0 
sample estimates: 
mean s1 - mean s3  
          -18.662 
 
data:  CRYAB R120G AAV GFP and WT AAV9 GFP 
p-value = 0.000777 
alternative hypothesis: true mean s3 - mean s4 is  0 
sample estimates: 
mean s3 - mean s4  
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17) Figure. 5G 
  
 
 Exact Permutation Test (complete enumeration) 
 
data:  CRYAB R120G AAV GFP vs. CRYABR120G AAV TFEB 
p-value = 0.003108 
alternative hypothesis: true mean s1 - mean s4 is  0 
sample estimates: 
mean s1 - mean s4  
         -31.3035 
 
data:  CRYABR120G AAV TFEB and WT AAV9 GFP 
p-value = 0.007937 
alternative hypothesis: true mean s1 - mean s3 is  0 
sample estimates: 
mean s1 - mean s3  
           44.326 
 
data:  CRYAB R120G AAV GFP and WT AAV9 GFP 
p-value = 0.000777 
alternative hypothesis: true mean s3 - mean s4 is  0 
sample estimates: 
mean s3 - mean s4  
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18) Figure. 5H 
  
 
 Exact Permutation Test (complete enumeration) 
 
data:  CRYAB R120G AAV GFP vs. CRYABR120G AAV TFEB 
p-value = 0.003108 
alternative hypothesis: true mean s1 - mean s4 is  0 
sample estimates: 
mean s1 - mean s4  
         -31.3035 
 
data:  CRYABR120G AAV TFEB and WT AAV9 GFP 
p-value = 0.007937 
alternative hypothesis: true mean s1 - mean s3 is  0 
sample estimates: 
mean s1 - mean s3  
           44.326 
 
data:  CRYAB R120G AAV GFP and WT AAV9 GFP 
p-value = 0.000777 
alternative hypothesis: true mean s3 - mean s4 is  0 
sample estimates: 
mean s3 - mean s4  
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 Exact Permutation Test (complete enumeration) 
 
data:  HSPB8/ACTIN WT AAV GFP vs. WT AAV TFEB 
p-value = 0.0303 
alternative hypothesis: true mean s2 - mean s3 is  0 
sample estimates: 
mean s2 - mean s3  
         1.144588 
 
data:  HSPB8/ACTIN WT AAV GFP vs. CRYAB R120G AAV GFP 
p-value = 0.002165 
alternative hypothesis: true mean s3 - mean s4 is  0 
sample estimates: 
mean s3 - mean s4  
        -3.923404 
 
 
data:  HSPB8/ACTIN CRYAB R120G AAV GFP vs. CRYAB R120G AAV TFEB 
p-value = 0.01166 
alternative hypothesis: true mean s1 - mean s4 is  0 
sample estimates: 
mean s1 - mean s4  
         2.077214 
 
data:  HSPB8/ACTIN WT AAV GFP vs. CRYAB R120G AAV TFEB 
p-value = 0.001263 
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sample estimates: 
mean s1 - mean s3  
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20) Figure 6D 
 
 Exact Permutation Test (complete enumeration) 
 
data:  HSPB1/ACTIN WT AAV GFP vs. CRYABR120G AAV GFP 
p-value = 0.01786 
alternative hypothesis: true mean s1 - mean s3 is  0 
sample estimates: 
mean s1 - mean s3  
         3.960078 
 
data:  HSPB1/ACTIN WT AAV TFEB vs. CRYABR120G AAV TFEB 
p-value = 0.007937 
alternative hypothesis: true mean s1 - mean s2 is  0 
sample estimates: 
mean s1 - mean s2  
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21) Figure 6E 
 
 
 Exact Permutation Test (complete enumeration) 
 
data:  DESMIN/ACTIN WT AAV GFP vs. CRYAB R120G AAVGFP 
p-value = 0.002165 
alternative hypothesis: true mean s3 - mean s4 is  0 
sample estimates: 
mean s3 - mean s4  
        -1.840548 
 
data:  DESMIN/ACTIN WT AAV TFEB vs. CRYAB R120G AAVTFEB 
p-value = 0.001166 
alternative hypothesis: true mean s1 - mean s2 is  0 
sample estimates: 
mean s1 - mean s2  
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22) Figure 7D 
 
 
                                     S1    S4     S2    S5    S3    S6 
 
 
 Exact Permutation Test (complete enumeration) 
 
data:  JC-1 DEPOLARIZATION: Ad LacZ + Ad CRYAB R120G  vs. Ad TFEB + Ad CRYAB 
R120G   
p-value = 0.0005828 
alternative hypothesis: true mean s13 - mean s14 is  0 
sample estimates: 
mean s13 - mean s14  
           1.747366  
 
data:  JC-1 depol.: Ad TFEB + Ad CRYAB R120G  vs. Ad TFEB + Ad CRYAB R120G + Ad 
sh-HSPB8 
p-value = 0.0005828 
alternative hypothesis: true mean s14 - mean s15 is  0 
sample estimates: 
mean s14 - mean s15  
          -1.709391 
 
data:  JC-1 DEPOLARIZATION: Ad LacZ vs. Ad LacZ + Ad CRYAB R120G   
p-value = 0.0005828 
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sample estimates: 
mean s10 - mean s13  
          -2.200875  
 
data:  JC-1 DEPOLARIZATION: Ad LacZ vs. Ad TFEB + Ad CRYAB R120G   
p-value = 0.0005828 
alternative hypothesis: true mean s10 - mean s14 is  0 
sample estimates: 
mean s10 - mean s14  
         -0.4535086  
 
data:  JC-1 DEPOLARIZATION: Ad LacZ vs. Ad LacZ + Ad shHSPB8   
p-value = 0.0005828 
alternative hypothesis: true mean s10 - mean s12 is  0 
sample estimates: 
mean s10 - mean s12  
         -0.4109876  
 
data:  JC-1 DEPOLARIZATION: Ad LacZ vs. Ad TFEB+ AD CRYABR120G + Ad shHSPB8   
p-value = 0.0005828 
alternative hypothesis: true mean s10 - mean s15 is  0 
sample estimates: 
mean s10 - mean s15  
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23) Figure 7E 
 
Mitochondrial DNA quantitation 
 Exact Permutation Test (complete enumeration) 
 
data:  MitoDNA:  Ad LacZ + Ad CRYAB R120G  vs. Ad TFEB + Ad CRYAB R120G   
p-value = 0.02857 
alternative hypothesis: true mean s13 - mean s14 is  0 
sample estimates: 
mean s13 - mean s14  
             0.4075  
 
data:  MitoDNA:  Ad TFEB + Ad CRYAB R120G  vs. Ad TFEB + Ad CRYAB R120G + Ad 
sh-HSPB8 
p-value = 0.02857 
alternative hypothesis: true mean s14 - mean s15 is  0 
sample estimates: 
mean s14 - mean s15  
              -0.44  
 
 
data:  MitoDNA: Ad LacZ vs. Ad LacZ + Ad CRYAB R120G   
p-value = 0.02857 
alternative hypothesis: true mean s10 - mean s13 is  0 
sample estimates: 
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            -0.6975  
          -2.200875  
 
data:  MitoDNA: Ad LacZ vs. Ad TFEB + Ad CRYAB R120G   
p-value = 0.02857 
alternative hypothesis: true mean s10 - mean s14 is  0 
sample estimates: 
mean s10 - mean s14  
              -0.29  
 
data:  MitoDNA: Ad LacZ vs. Ad LacZ + Ad shHSPB8   
p-value = 0.02857 
alternative hypothesis: true mean s10 - mean s12 is  0 
sample estimates: 
mean s10 - mean s12  
            -0.3775  
 
data:  MitoDNA:Ad LacZ vs. Ad TFEB+ AD CRYABR120G + Ad shHSPB8   
p-value = 0.02857 
alternative hypothesis: true mean s10 - mean s15 is  0 
sample estimates: 
mean s10 - mean s15  
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24) Figure 7F 
 
  
S1    S4     S2    S5    S3    S6 
 
Exact Permutation Test (complete enumeration) 
 
data:  Ad LacZ + Ad CRYAB R120G  vs. Ad TFEB + Ad CRYAB R120G   
p-value = 0.0001554 
alternative hypothesis: true mean s4 - mean s5 is  0 
sample estimates: 
mean s4 - mean s5  
         6.829617 
 
data:  Ad TFEB + Ad CRYAB R120G  vs. Ad TFEB + Ad CRYAB R120G + Ad sh-HSPB8 
p-value = 0.0001554 
alternative hypothesis: true mean s5 - mean s6 is  0 
sample estimates: 
mean s5 - mean s6  
        -7.874323 
 
data: Ad LacZ vs. Ad LacZ + Ad CRYAB R120G   
p-value = 0.0001554 
alternative hypothesis: true mean s1 - mean s4 is  0 
sample estimates: 
mean s1 - mean s4  
         -9.49469  
 
data:  Ad LacZ vs. Ad TFEB + Ad CRYAB R120G   
p-value = 0.006838 
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sample estimates: 
mean s1 - mean s5  
        -2.665073 
 
data: Ad LacZ vs. Ad LacZ + Ad shHSPB8   
p-value = 0.02455 
alternative hypothesis: true mean s1 - mean s3 is  0 
sample estimates: 
mean s1 - mean s3  
         -1.78758 
 
data: Ad LacZ vs. Ad TFEB+ AD CRYABR120G + Ad shHSPB8   
p-value = 0.0001554 
alternative hypothesis: true mean s1 - mean s6 is  0 
sample estimates: 
mean s1 - mean s6  
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25) Figure 8B 
  
Exact Permutation Test (complete enumeration) 
 
data:  AAV sh control and sh TFEB 
p-value = 0.02857 
alternative hypothesis: true mean s10 - mean s11 is  0 
sample estimates: 
mean s10 - mean s11  
          0.7235474  
 
data:  sh TFEB and sh HSPB8 
p-value = 0.02857 
alternative hypothesis: true mean s11 - mean s12 is  0 
sample estimates: 
mean s11 - mean s12  
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26) Figure 8C 
 
 
data:  sh Control and sh TFEB 
p-value = 0.02857 
alternative hypothesis: true mean s10 - mean s11 is  0 
sample estimates: 
mean s10 - mean s11  
          0.2165965  
 
data:  sh TFEB and sh HSPB8 
p-value = 0.02857 
alternative hypothesis: true mean s11 - mean s12 is  0 
sample estimates: 
mean s11 - mean s12  
          0.5273424  
 
data:  sh Control and sh HSPB8 
p-value = 0.02857 
alternative hypothesis: true mean s10 - mean s12 is  0 
sample estimates: 
mean s10 - mean s12  
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 Exact Permutation Test (complete enumeration) 
 
data:  sh Control baseline and sh Control 6wk 
p-value = 0.03968 
alternative hypothesis: true mean s10 - mean s30 is  0 
sample estimates: 
mean s10 - mean s30  
            -7.7552  
 
data:  sh control baseline and shHSPB8 baseline 
p-value = 0.07937 
alternative hypothesis: true mean s20 - mean s21 is  0 
sample estimates: 
mean s20 - mean s21  
             9.0979 
 
data:  sh Control 6wk and sh TFEB 6wk 
p-value = 0.007937 
alternative hypothesis: true mean s30 - mean s31 is  0 
sample estimates: 
mean s30 - mean s31  
            14.0881 
 
data:  sh Control 6wk and sh HSPB8 6wk 
p-value = 0.007937 
alternative hypothesis: true mean s30 - mean s32 is  0 
sample estimates: 
mean s30 - mean s32  
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